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A B S T R A C T
Background
An eEective way of preventing sudden cardiac death is the use of an implantable cardioverter defibrillator (ICD). In spite of the potential
mortality benefits of receiving an ICD device, psychological problems experienced by patients aJer receiving an ICD may negatively
impact their health-related quality of life, and lead to increased readmission to hospital and healthcare needs, loss of productivity and
employment earnings, and increased morbidity and mortality. Evidence from other heart conditions suggests that cardiac rehabilitation
should consist of both exercise training and psychoeducational interventions; such rehabilitation may benefit patients with an ICD. Prior
systematic reviews of cardiac rehabilitation have excluded participants with an ICD. A systematic review was therefore conducted to assess
the evidence for the use of exercise-based intervention programmes following implantation of an ICD.
Objectives
To assess the benefits and harms of exercise-based cardiac rehabilitation programmes (exercise-based interventions alone or in
combination with psychoeducational components) compared with control (group of no intervention, treatment as usual or another
rehabilitation programme with no physical exercise element) in adults with an ICD.
Search methods
We searched CENTRAL, MEDLINE, Embase and four other databases on 30 August 2018 and three trials registers on 14 November 2017. We
also undertook reference checking, citation searching and contacted study authors for missing data.
Selection criteria
We included randomised controlled trials (RCTs) if they investigated exercise-based cardiac rehabilitation interventions compared with no
intervention, treatment as usual or another rehabilitation programme. The trial participants were adults (aged 18 years or older), who had
been treated with an ICD regardless of type or indication.
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Data collection and analysis
Two review authors independently extracted data and assessed risk of bias. The primary outcomes were all-cause mortality, serious
adverse events and health-related quality of life. The secondary outcomes were exercise capacity, antitachycardia pacing, shock, non-
serious adverse events, employment or loss of employment and costs and cost-eEectiveness. Risk of systematic errors (bias) was assessed
by evaluation of predefined bias risk domains. Clinical and statistical heterogeneity were assessed. Meta-analyses were undertaken using
both fixed-eEect and random-eEects models. We used the GRADE approach to assess the quality of evidence.
Main results
We identified eight trials published from 2004 to 2017 randomising a total of 1730 participants, with mean intervention duration of 12
weeks. All eight trials were judged to be at overall high risk of bias and eEect estimates are reported at the end of the intervention with
a follow-up range of eight to 24 weeks.
Seven trials reported all-cause mortality, but deaths only occurred in one trial with no evidence of a diEerence between exercise-based
cardiac rehabilitation and control (risk ratio (RR) 1.96, 95% confidence interval (CI) 0.18 to 21.26; participants = 196; trials = 1; quality of
evidence: low). There was also no evidence of a diEerence in serious adverse events between exercise-based cardiac rehabilitation and
control (RR 1.05, 95% CI 0.77 to 1.44; participants = 356; trials = 2; quality of evidence: low). Due to the variation in reporting of health-
related quality of life outcomes, it was not possible to pool data. However, the five trials reporting health-related quality of life at the end
of the intervention, each showed little or no evidence of a diEerence between exercise-based cardiac rehabilitation and control.
For secondary outcomes, there was evidence of a higher pooled exercise capacity (peak VO2) at the end of the intervention (mean diEerence
(MD) 0.91 mL/kg/min, 95% CI 0.60 to 1.21; participants = 1485; trials = 7; quality of evidence: very low) favouring exercise-based cardiac
rehabilitation, albeit there was evidence of substantial statistical heterogeneity (I2 = 78%). There was no evidence of a diEerence in the risk
of requiring antitachycardia pacing (RR 1.26, 95% CI 0.84 to 1.90; participants = 356; trials = 2; quality of evidence: moderate), appropriate
shock (RR 0.56, 95% CI 0.20 to 1.58; participants = 428; studies = 3; quality of evidence: low) or inappropriate shock (RR 0.60, 95% CI 0.10
to 3.51; participants = 160; studies = 1; quality of evidence: moderate).
Authors' conclusions
Due to a lack of evidence, we were unable to definitively assess the impact of exercise-based cardiac rehabilitation on all-cause mortality,
serious adverse events and health-related quality of life in adults with an ICD. However, our findings do provide very low-quality evidence
that patients following exercise-based cardiac rehabilitation experience a higher exercise capacity compared with the no exercise control.
Further high-quality randomised trials are needed in order to assess the impact of exercise-based cardiac rehabilitation in this population
on all-cause mortality, serious adverse events, health-related quality of life, antitachycardia pacing and shock.
P L A I N   L A N G U A G E   S U M M A R Y
Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator
Review question
We reviewed the benefits and harms of exercise-based cardiac rehabilitation programmes in adults who have been treated with an
implantable cardioverter defibrillator from any cause.
Background
An implantable cardioverter defibrillator is a very eEective device that prevents sudden cardiac death. This is done by the use of either
antitachycardia pacing, high-voltage shock therapy, or both. In spite of the potential mortality benefits, patients may also experience
a negative impact on their health-related quality of life, increased readmission to hospital and healthcare facilities, loss of productivity
and employment earnings, and increased morbidity and mortality. Exercise-based cardiac rehabilitation may benefit patients with an
implantable cardioverter defibrillator.
Study characteristics
We searched for randomised controlled trials (experiments in which participants are randomly allocated to an experimental intervention
compared with a control intervention) that investigated exercise-based interventions compared with no exercise intervention control. We
found eight trials published from 2004 to 2017 with a total of 1730 participants. Two trials did not report on funding and one trial reported
funding from industry. The evidence is current to 30 August 2018.
Key results
The review showed no evidence of an impact on the risk of death, harmful side eEects or having antitachycardia pacing or shock therapy
when comparing the exercise intervention to the control. There was also little or no evidence of a diEerence on health-related quality of
life. However, there was an improvement in exercise capacity in favour of the exercise group.
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Quality of the evidence
The quality of the evidence ranged from moderate to very low for all outcomes. The number of events was low, it was possible for people
in the trials to know to which intervention group they were randomised, the reporting of the results was not complete in some trials, and
for some outcomes, the results varied across trials. These considerations limited our confidence in the overall results of the review.
Conclusion
Further adequately powered and well-conducted randomised trials are needed to assess the impact of exercise-based cardiac
rehabilitation in adults with an implantable cardioverter defibrillator.
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Summary of findings for the main comparison.   Exercise compared to no exercise at the end of the intervention for adults with an implantable
cardioverter defibrillator
Exercise compared to no exercise at the end of the intervention for adults with an implantable cardioverter defibrillator
Patient or population: adult patients with an implantable cardioverter defibrillator
Setting: in-hospital, outpatient clinic, home-based
Intervention: exercise
Comparison: no exercise
Anticipated absolute effects* (95% CI)Outcomes
Risk with no exercise Risk with exercise
Relative ef-
fect
(95% CI)
№ of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Study populationAll-cause mortality
(follow-up: range 8 weeks to 24
weeks) 10 per 1000 20 per 1000
(2 to 219)
RR 1.96
(0.18 to
21.26)
196
(1 RCTs)
⊕⊕⊝⊝
Low b c
Seven trials with a
total of 677 partici-
pants reported all-
cause mortality. Six
trials reported no
deaths and one trial
reported a total of 3
deaths.
Study populationSerious adverse events
(follow-up: range 12 weeks to 24
weeks) 277 per 1000 291 per 1000
(214 to 400)
RR 1.05
(0.77 to 1.44)
356
(2 RCTs)
⊕⊕⊝⊝
Low b c
One additional study
reported that no se-
rious adverse events
occurred (Piotrowicz
2015).
Exercise-capacity (VO2 peak)
(follow-up: range 8 weeks to 24
weeks)
The mean exercise-capacity (VO2
peak) was 17.23 mL/kg/min
MD 0.91 mL/kg/min
higher
(0.60 higher to 1.21
higher)
- 1485
(7 RCTs)
⊕⊝⊝⊝
Very low d e f
 
Study populationICD, antitachycardia pacing
(follow-up: range 12 weeks to 24
weeks) 168 per 1000 211 per 1000
(141 to 318)
RR 1.26
(0.84 to 1.90)
356
(2 RCTs)
⊕⊕⊕⊝
Moderate c
 
Study populationICD, appropriate shock
(follow-up: range 8 weeks to 24
weeks) 132 per 1000 74 per 1000
RR 0.56
(0.20 to 1.58)
428
(3 RCTs)
⊕⊕⊝⊝
Low c d
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(26 to 209)
Study populationICD, inappropriate shock
(follow-up: 24 weeks)
39 per 1000 24 per 1000
(4 to 139)
RR 0.60
(0.10 to 3.51)
160
(1 RCTs)
⊕⊕⊕⊝
Moderatec
One additional study
reported that no in-
appropriate shocks
occurred (Piotrowicz
2015).
Health-related quality of life
(HRQoL)
(assessed with different scales -
follow-up: range 8 weeks to 24
weeks)
One trial reported the official version of SF-36 showing
evidence of a greater improvement in the exercise-based
cardiac rehabilitation group on SF-36 Mental Component
Score but no difference in Physical Component Score.
One trial reported another version of SF-36 showing no
evidence of a difference between the groups. One trial
reported the Nottingham Health Profile showing no ev-
idence of a difference between the groups. One trial re-
ported the Minnesota Living with Heart Failure showing
no evidence of a difference between the groups. One tri-
al reported the EuroQual showing no evidence of a differ-
ence between the groups.
- 433
(5 RCTs)
⊕⊝⊝⊝
Very low a g
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; ICD: implantable cardioverter defibrillator; HRQoL: health-related quality of life; MD: mean difference; RCT: randomised controlled trial; RR: risk ra-
tio.
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect
a Random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, performance bias
where poorly described in over 50% of included studies; risk of bias (downgraded by 2 levels).
b Not enough number of events to calculate a precise eEect estimate, risk of imprecision (downgraded by 1 level).
c The 95% CIs includes both no eEect and appreciable harm (i.e. CI > 1.25) and appreciable benefit (i.e. CI < 0.75), risk of imprecision (downgraded by 1 level).
d Random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, performance bias
where poorly described in less then 50% of included studies; risk of bias (downgraded by 1 level).
e There was a degree of variability between studies of 50% to 90%, which might represent substantial heterogeneity, risk of inconsistency (downgraded by 1 level).
f The upper or lower confidence limit crosses the eEect size of 0.5 in either direction, risk of imprecision (downgraded by 1 level).
g There is some degree of inconsistency in the results, risk of inconsistency (downgraded by 1 level).
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Summary of findings 2.   Exercise compared to no exercise at longest available follow-up for adults with an implantable cardioverter defibrillator
Exercise compared to no exercise at longest available follow-up for adults with an implantable cardioverter defibrillator
Patient or population: adult patients with an implantable cardioverter defibrillator
Setting: in-hospital, outpatient clinic, home-based
Intervention: exercise
Comparison: no exercise
Anticipated absolute effects* (95% CI)Outcomes
Risk with no exercise Risk with exercise
Relative ef-
fect
(95% CI)
№ of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Study populationAll-cause mortality
(follow-up: range 12 months to 45
months) 127 per 1000 149 per 1000
(82 to 271)
RR 1.18
(0.65 to 2.14)
332
(3 RCTs)
⊕⊝⊝⊝
Very lowb c e
Four trials with a to-
tal of 384 partici-
pants reported all-
cause mortality. One
trial reported no
deaths and three tri-
als reported a total
of 46 deaths.
Study populationSerious adverse events
(follow-up: range 12 months to 18
months) 527 per 1000 427 per 1000
(322 to 570)
RR 0.81
(0.61 to 1.08)
188
(3 RCTs)
⊕⊝⊝⊝
Very low a c d
 
Exercise-capacity (VO2 peak)
(follow-up: mean 12 months)
The mean exercise-capacity (VO2
peak) was 14.5 mL/kg/min
MD 0.83 mL/kg/min
higher
(0.66 lower to 2.32
higher)
- 136
(2 RCTs)
⊕⊝⊝⊝
Very low a c
 
ICD, antitachycardia pacing
(follow-up: 45 months)
One trial with a total of 196 participants reported re-
sults on antitachycardia pacing at 45 months of fol-
low-up with no evidence of a difference between ex-
ercise-based cardiac rehabilitation and control group
(Berg 2014).
- 196
(1RCT)
⊕⊝⊝⊝
Very low a b
 
Study populationICD, appropriate shock
(follow-up: range 12 months to 45
months) 356 per 1000 100 per 1000
(18 to 588)
RR 0.28
(0.05 to 1.65)
384
(4 RCTs)
⊕⊝⊝⊝
Very low a c d
 
ICD, all shocks
(follow-up: mean 26 months)
Study population RR 0.89
(0.70 to 1.12)
1053
(1 RCT)
⊕⊕⊝⊝
Very low a c
No study reported in-
appropriate shock
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198 per 1000 176 per 1000
(138 to 222)
at the longest avail-
able follow-up. We
therefore report on
all shocks.
HRQoL
(assessed with Nottingham Health
Profile score -
follow-up: 12 months)
One trial with a total of 52 participants reported results
on HRQoL at 12 months of follow-up with no evidence of
a difference between exercise-based cardiac rehabilita-
tion and control group on the total Nottingham Health
Profile score (Smolis-Bak 2015).
- 52
(1 RCT)
⊕⊝⊝⊝
Very low a b
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; HRQoL: health-related quality of life; ICD: implantable cardioverter defibrillator; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect
a Random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, performance bias
where poorly described in over 50% of included studies; bias likely, therefore quality of evidence was downgraded by two levels.
b Not enough number of events to calculate a precise eEect estimate, risk of imprecision (downgraded by 1 level).
c The 95% CIs includes both no eEect and appreciable harm (i.e. CI > 1.25) and appreciable benefit (i.e. CI < 0.75), therefore quality of evidence was downgraded by one level.
d There was a degree of variability between studies of 50% to 90%, which might represent substantial heterogeneity (downgraded by 1 level)
e Random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, performance bias
where poorly described in less then 50% of included studies; risk of bias (downgraded by 1 level).
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B A C K G R O U N D
Description of the condition
Cardiovascular disease is a leading cause of global mortality with
approximately 17.3 million deaths each year (2009-2012) and this
figure is expected to rise to 23.6 million by 2030 (MozaEarian 2015).
A major cause of cardiovascular deaths are sudden cardiac death;
even though absolute rates of sudden cardiac death are declining
it remains a significant public health burden (Niemeijer 2015).
An eEective way of preventing sudden cardiac death, and
one of the reasons for the decline is the use of implantable
cardioverter defibrillators (ICDs) (Niemeijer 2015). An ICD can
perform both monitoring and diagnosis of arrhythmia, but its
main function is to give therapy to potentially life-threatening
ventricular tachyarrhythmia, including ventricular tachycardia and
ventricular fibrillation by use of antitachycardia pacing and high-
voltage shock therapy, respectively. In addition to this, an ICD can
give conventional bradycardia pacing if the patient has episodes
of bradyarrhythmia. It is well documented that ICD shock and
antitachycardia pacing can reduce mortality in patients with
previous cardiac arrest due to ventricular tachyarrhythmia, and
in primary prevention studies ICD implantation has been shown
beneficial in patients with symptomatic heart failure despite
optimal medical therapy and reduced contractile function. The
implantation of an ICD is very similar to a conventional pacemaker
with a lead in the right ventricle connected to the ICD which is
typically positioned subcutaneously on the anterior chest wall
below the clavicle (Tracy 2012). In recent years, primary prevention
ICD treatment, either with or without cardiac re synchronisation
therapy, has been extended to patients with symptomatic heart
failure as part of the Heart Failure Guidelines from the American
College of Cardiology/American Heart Association and European
Society of Cardiology (Ponikowski 2016; Yancy 2013). This has led to
a marked increase in the implantation rates in the USA and Europe
(Gersh 2011; Jessup 2009). In 2013, the ICD implantation rate for
first-time implants was approximately 214 per million inhabitants
in the Nordic Countries (Denmark, Sweden and Norway) and
approximately 125 per million inhabitants in the UK (Kuck 2014).
These numbers are low compared with the USA, where the
implantation rate in 2006 was almost twice as high, with 370 per
million inhabitants (Scott 2009).
In addition to preventing sudden cardiac death, a number
of randomised controlled trials (RCTs) has shown that the
implantation of an ICD (either alone or in combination with
cardiac resynchronisation therapy) in both the primary and
secondary prevention setting has significant mortality and
health-related quality of life eEects (Mark 2008; Schron 2002).
Adverse events for ICD recipients are mostly implantation-related
complications (coronary vein dissection, coronary vein perforation,
lead dislodgement, infection and death) and inappropriate
defibrillator shocks (Kirkfeldt 2014). Patients who experience
defibrillator shocks may experience psychological diEiculties (Berg
2014; Dunbar 2009; Lemon 2004). A systematic review of anxiety
and depression in ICD participants that included 45 studies and
more than 5000 patients concluded that approximately 20% of ICD
patients have clinically significant psychological distress (Magyar-
Russell 2011). This is twice as high as in individuals with general
cardiac and chronic medical conditions (Lichtman 2008).
In spite of the potential mortality benefits of receiving an ICD
device, psychological problems experienced by patients aJer
receiving an ICD may negatively impact their health-related
quality of life, and lead to increased readmission to hospital and
healthcare needs, loss of productivity and employment earnings,
and increased morbidity and mortality (Berg 2014; Dunbar 2012;
Lemon 2004; Thomas 2001).
Description of the intervention
Cardiac rehabilitation is a comprehensive, complex intervention
that includes components of exercise training, education,
psychosocial management and a behaviour-modification
programme designed to improve the physical and emotional
conditions of people with heart disease (Piepoli 2010).
Cardiac rehabilitation includes, for example, patient assessment,
nutritional counselling, and risk factor management for lipids,
blood pressure, weight, diabetes mellitus and smoking cessation
(Piepoli 2010).
The beneficial eEects of cardiac rehabilitation in post-myocardial,
revascularisation and heart failure patients is well established
in terms of potential reductions in mortality, hospitalisation and
healthcare costs, as well as improvements in exercise capacity and
health-related quality of life (Adamopoulos 1993; Anderson 2016;
Belardinelli 1995; Coats 1992; Piepoli 2010; Sullivan 1988; Taylor
2014; Wilson 1996).
The European Society of Cardiology recommends that exercise
training for people with cardiovascular disease should consist of
two and a half hours per week, but recommendations stretch to
four hours per week (Piepoli 2010).
Although their psychological needs may be high, no specific
evidence-based cardiac rehabilitation guidelines exist for patients
with ICDs, as evidence concerning rehabilitation for this patient
group is very limited (Berg 2014; Dunbar 2012; Isaksen
2012). Neither the European Society of Cardiology nor the
American Heart Association/American College of Cardiology
have published separate or specific guidelines on exercise
training for the ICD patient. We have been unable to identify
any international consensus reports or guidelines that provide
detailed recommendations for exercise training aJer receiving
an ICD. Consequently, recommendations for ICD patients
regarding exercise training vary widely (Isaksen 2012). RCTs and
observational studies evaluating the eEect of physical exercise
for ICD patients have employed many diEerent training protocols
(Isaksen 2012).
Current cardiac rehabilitation recommendations for post-
myocardial infarction/revascularisation, heart failure and heart
valve replacement patients recommend that, in addition to
exercise training, psychosocial or educational support, or both,
should be oEered (Piepoli 2010); so-called 'comprehensive
cardiac rehabilitation'. However, as with exercise training, there
are no separate or specific guidelines on psychoeducational
interventions for the ICD patient. Many psychoeducational
intervention studies in ICD recipients, some of which are RCTs,
have reported improvements in anxiety, depression and health-
related quality of life outcomes, as well as fewer unplanned
hospital admissions and phone calls to healthcare providers
compared with the control group (Berg 2014; Dunbar 2009;
Lewin 2009; Pedersen 2007). Some of these studies have
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employed diEerent psychoeducational intervention protocols,
which again reflect the uncertainty surrounding the specific nature
of cardiac rehabilitation for patients with ICDs and what kind of
psychoeducational intervention they should receive.
In summary, there is evidence from other heart conditions
(post-myocardial infarction, revascularisation and heart failure)
that suggests that cardiac rehabilitation for patients with ICD
should consist of both exercise training and psychoeducational
intervention, but evidence-based rehabilitation guidelines for ICD
recipients are currently lacking.
How the intervention might work
Studies of exercise training or psychoeducational interventions, or
both, in ICD patients have reported improvements in psychological
outcomes or physical outcomes, or both (Belardinelli 2006; Berg
2014; Davids 2005; Dougherty 2005; Dougherty 2008; Dunbar 2009;
Fan 2009; Fitchet 2003; Irvine 2011; Vanhees 2004). RCTs have
reported that comprehensive cardiac rehabilitation significantly
increased average peak oxygen uptake (VO2) aJer exercise training,
with improvements of 16% to 27% in metabolic equivalents
(METS) or peak VO2 (Belardinelli 2006; Berg 2014; Davids 2005;
Fan 2009; Fitchet 2003; Vanhees 2004). A retrospective study of
82 ICD recipients indicated that patients who did not participate
in outpatient rehabilitation had a higher rate of ICD shock
therapy than ICD recipients who participated in outpatient
rehabilitation, aJer adjusting for physical limitations (Davids
2005). Randomised trials have also reported reduced anxiety and
depressive symptoms, increased health-related quality of life and
decreased disability days/calls to healthcare providers (Belardinelli
2006; Berg 2014; Dougherty 2005; Dougherty 2008; Dunbar
2009; Fitchet 2003; Irvine 2011). As exercise-based rehabilitation
emphases aspects of behavioural change (e.g. exercise/physical
activity levels, improvements in diet and adherence to medication),
beneficial eEects may extend beyond the initial intervention period
where patients are in direct contact with rehabilitation providers.
The safety of exercise training aJer ICD implantation may be
compromised due to the risk of inappropriate ICD shocks.
Therefore, patients are uncertain as to the level of exercise that is
safe to perform without receiving an ICD shock. However, several
studies have shown only a few exercise-related cardiac events
during or soon aJer the training session (Berg 2014; Dougherty
2008; Fan 2009; Vanhees 2004).
In summary, randomised and observational studies suggest that
exercise training has a positive eEect on the exercise capacity,
general health and quality of life of ICD patients. Furthermore,
inclusion of psychosocial or educational support may have positive
eEects in terms of reduced anxiety and depression.
Why it is important to do this review
Firstly, whilst summaries of the evidence for cardiac rehabilitation
in patients with ICD have been published (Dunbar 2012; Isaksen
2012), we are unaware of any systematic reviews of trials in
this area. Secondly, we seek to extend the trial evidence base
considered by the Cochrane Review, Exercise-based rehabilitation
for heart failure (Taylor 2014). Many trials included in this Cochrane
Review excluded ICD implants. However, we are aware that some
of the more recent RCTs of exercise-based cardiac rehabilitation
for heart failure include a proportion of patients with ICD, e.g.
approximately 55% of patients in the HF-ACTION randomised trial
(O'Connor 2009). While these randomised trials were included in
the heart failure Cochrane Review, outcomes for the ICD subgroup
were not reported separately. This Cochrane Review will therefore
seek to report the outcomes for ICD subgroups included in those
heart failure trials.
As outlined above, a proportion of ICD patients have arrhythmia
(secondary prevention) and not heart failure (primary prevention).
Traditionally, the ICD population has been considered as a single
group due to their similar high risk of sudden cardiac death, ICD
shock and device-dependence. As cardiac rehabilitation studies
have been carried out in mixed ICD populations (both arrhythmia
and heart failure), we will seek to include patients of all indications
who have received an ICD, but aim to stratify our results by primary
versus secondary indication.
By conducting this review we will also add to the body of knowledge
about cardiac rehabilitation in complex cardiac conditions (Risom
2017; Sibilitz 2016; Taylor 2014).
O B J E C T I V E S
To assess the benefits and harms of exercise-based cardiac
rehabilitation programmes (exercise-based interventions alone or
in combination with psychoeducational components) compared
with control ( group of no intervention, treatment as usual or
another rehabilitation programme) in adults with an ICD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs irrespective of language, publication year,
publication type and publication status in the review.
Types of participants
We considered for inclusion adult participants (18 years or older), of
both sexes and all ethnicities, who have been treated with an ICD.
We included participants regardless of their indication or whether
the device was implanted for primary or secondary prevention of
sudden cardiac death. We included participants with ICD devices
combined with cardiac resynchronisation therapy and permanent
ICDs with any additional leads for pacing, including single chamber,
dual chamber and biventricular pacemakers. In trials that included
both participants with and without ICDs, we contacted trial authors
for separate data on the ICD participants. If this was not possible,
we only included the trial if at least 50% of participants were
ICD recipients or if the trial had less than 50% but presented the
results in a subgroup of ICD patients separately. We only found
one trial that included both participants with and without ICDs
(Chrysohoou 2015). As the number of ICD participants was below
50%, we contacted the lead author for separated data on the ICD
population; we are still waiting for this data and therefore the trial
awaits classification.
Types of interventions
Experimental
The experimental intervention included an exercise-based cardiac
rehabilitation programme for adults treated with an ICD. We
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defined interventions as 'exercise-based' when being either a
supervised or unsupervised programme conducted in an inpatient,
outpatient, community or home setting that included any kind
of exercise training. The intervention included a physical exercise
component that focused on increasing exercise capacity, and some
trials also included a psychoeducational intervention that focused
on improving mental health and the patient's self-management
skills. The exercise intervention must have been initiated aJer ICD
implantation. There was no restriction in the length, intensity or
content of the training programme and there was no minimum
length of follow-up for the studies that were eligible for inclusion in
the review.
Control
We included control interventions that excluded exercise training,
as listed below.
• Treatment as usual (e.g. standard medical care, such as ICD
follow-up).• No intervention.• Any other type of cardiac rehabilitation programme, as long as
it did not include a physical exercise element.
The included trials had diEerent approaches to the control group.
However, none of the trials reported any data on the control groups,
why it is not possible to diEerentiate between them. Therefore,
we grouped these three types of control into a single control and
therefore only refer to control throughout the review.
Co-interventions
We included trials when they had co-interventions other than
cardiac rehabilitation of any kind, as long as these were identical
and delivered equally in the experimental and control groups.
Co-interventions included anything other than the experimental
exercise intervention (e.g. drug delivery, surgery techniques or
dietary interventions).
Types of outcome measures
We assessed all outcomes at two time points as follows.
• End of the intervention (as defined by the trial authors).• Longest available follow-up aJer the intervention period.
We considered 'end of intervention' to be the primary time point of
interest.
Primary outcomes• All-cause mortality.• Serious adverse events, defined as any adverse event that
results in death, is life threatening, requires hospitalisation, or
results in persistent or significant disability or incapacity (ICH-
GCP 2015).• Health-related quality of life using generic or disease-specific
validated instruments, e.g. Short Form-36 (SF-36) (Ware 1992),
EuroQual (Brooks 1996) and Minnesota Living with Heart Failure
Questionnaire (Rector 1992).
Secondary outcomes• Exercise capacity: any measure of exercise capacity, including
direct measurement of VO2 peak or VO2 max or indirect
measures, such as exercise time, walking distance, etc.• ICD antitachycardia pacing.• ICD shock, defined as either inappropriate shock, appropriate
shock or all shock (if it is not clear wether shock is appropriate
or inappropriate).• Non-serious adverse events, such as musculoskeletal injury,
palpitations, dyspnoea, dizziness.• Employment or loss of employment.• Costs and cost-eEectiveness of cardiac rehabilitation.
Search methods for identification of studies
Electronic searches
We identified trials through systematic searches of the following
bibliographic databases on 30 August 2018.
• Cochrane Central Register of Controlled Trials (CENTRAL Issue 8
of 12, 2018) in the Cochrane Library.• Epub Ahead of Print, In-Process & Other Non-Indexed Citations,
MEDLINE Daily and MEDLINE (Ovid, 1946 to 30 August 2018).• Embase (Ovid, 1980 to 2018 Week 34).• CINAHL Plus (EBSCO, 1937 to 30 August 2018).• PsycINFO (Ovid, 1806 to August week 4 2018).• LILACS (Bireme, 1982 to 30 August 2018).• Conference Proceedings Citation Index-Science (CPCI-S) on Web
of Science (Clarivate Analytics, 1990 to 30 August 2018).
We adapted the preliminary search strategy for MEDLINE (Ovid) for
use in the other databases (Appendix 1). We applied the Cochrane
sensitivity-maximising RCT filter to MEDLINE (Ovid) (Lefebvre 2011),
and adapted it to the other databases, except CENTRAL.
We searched all databases from their inception and did not impose
any date or language of publication restrictions.
Searching other resources
We searched the following clinical trials registers on 14 November
2017 to identify ongoing trials. See the search strategy in Appendix
1.
• ClinicalTrial.gov (www.clinicaltrials.gov).• Controlled-trials.com (www.controlled-trials.com).• World Health Organization (WHO) International Clinical Trials
Registry Platform (ICTRP) (apps.who.int/trialsearch/).
We checked the reference lists of all primary studies and relevant
publications for additional references to relevant trials and any
unidentified RCTs. Finally, we also searched articles that had cited
the included trials.
Data collection and analysis
Selection of studies
Two review authors, KMN and SKB, independently screened the
titles and abstracts of all the potential studies that were identified
as a result of the search, and coded them as 'retrieve' (eligible or
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potentially eligible/unclear) or 'do not retrieve'. If there were any
queries, the full-text was retrieved. Two review authors, KMN and
SKB, independently screened the full-text and identified studies
for inclusion, and identified and recorded reasons for exclusion of
the ineligible studies. Any disagreements were resolved through
discussion or, if required, a third review author (RST) was consulted.
The selection process was recorded in suEicient detail to complete
a PRISMA flow diagram (Figure 1), and the 'Characteristics of
excluded studies' table.
 
Figure 1.   Study flow diagram.
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Data extraction and management
Two review authors (KMN and SKB) independently extracted trial
data from the included RCTs using standardised data extraction
forms. For the trial conducted by SKB, data were extracted by RST,
who was not involved in the trial (Berg 2014). Data were presented
both in tables and text and we resolved any discrepancies
by consensus. KMN entered all data into Cochrane's statistical
soJware Review Manager 5 (Review Manager 2014). It was double-
checked that data were entered correctly by comparing the data
presented in the systematic review with the study reports. A second
review author, SKB, spot-checked study characteristics entered in
Review Manager 5 for accuracy against the trial report. In cases
where there were not suEicient data or data were unclear in the
included RCTs, we contacted trial authors to clarify the missing or
unclear data. We extracted the following data.
• General information: publication status, title, authors' names,
source, country, contact address, language of publication, year
of publication, and duplicate publication.• Methods: study design, total duration of study, details of any
'run in' period, number of study centres and location, study
setting, withdrawals, and date of study.• Participants: number randomised, mean age, age range, sex,
severity of condition, diagnostic criteria, baseline lung function,
smoking history, inclusion criteria, exclusion criteria, and
number of participants lost to follow-up.• Interventions: type of physical exercise, type of rehabilitation
programme (does it consist of only physical exercise or are
there any other components included, e.g. psychoeducational
intervention, diet intervention, behavioural intervention),
setting (e.g. inpatient, outpatient, community, home setting or
a combination), time aJer hospitalisation, and type of control
intervention.• Outcomes: primary and secondary outcomes specified and
collected, and time points reported. Please see Types of
outcome measures.• Bias: please see Assessment of risk of bias in included studies.• Notes: trial funding and notable conflicts of interest of trial
authors.
Assessment of risk of bias in included studies
Two review authors (KMN and SKB) independently assessed
risk of bias for each study using the core criteria outlined in
the Cochrane Handbook for Systematic Reviews of Interventions:
generation of random sequence and allocation concealment,
blinding of participants and personnel, blinding of outcome
assessment, incomplete outcome data, and selective outcome
reporting (Higgins 2011a). In addition to these core items and in
accordance with previous Cochrane cardiac rehabilitation Reviews
(Risom 2017; Sibilitz 2016), we assessed three other possible
sources of bias: performance bias (relating to co-interventions),
intention-to-treat analysis, and groups balanced at baseline. We
resolved any disagreements by discussion or by involving another
review author (RST). We judged the 'Risk of bias' criteria as either
'low', 'high' or 'unclear' risk and evaluated individual bias items as
described in Higgins 2011a. The criteria for all items were detailed
in Appendix 2.
Overall risk of bias
We categorised a trial as being at low risk of bias if we rated the
trial at low risk in all the domains listed above. We categorised a
trial as being at high risk of bias if we rated the risk of bias as either
uncertain or high in any of the domains listed above. We expected
though, that we would categorise all trials as an overall high risk
of bias, as it was not possible to blind participants and personnel
(Savović 2012; Wood 2008). Therefore, we categorised trials at
overall low risk of bias if we rated a trial at low risk of bias in all the
risk of bias domains listed above, except blinding of participants
and personnel. We also took into account the risk of bias of the trials
that contributed to that outcome, when considering intervention
eEects.
Measures of treatment e;ect
We expressed results of dichotomous outcomes as risk ratios (RRs)
with 95% confidence intervals (CIs). We estimated continuous
outcomes as the mean diEerence (MD) with 95% CIs between
intervention groups. Whilst standardised mean diEerence (SMD)
can be calculated if diEerent instruments across trials assessing the
same outcome are used, given the range of reported instruments
and domains, we did not calculate SMDs for health-related quality
of life outcomes in this review. Instead we provide a tabular
summary of exercise-based cardiac rehabilitation versus control
health-related quality of life outcome results, as reported by
studies.
Unit of analysis issues
We only included RCTs with an individual allocation and parallel
design. The trial of Belardinelli 2006 was designed as a cross-over
RCT, therefore we only used data from the first part of the trial
before cross-over.
Dealing with missing data
We contacted investigators or study sponsors in order to verify key
trial characteristics and missing outcome data.
Assessment of heterogeneity
We explored clinical heterogeneity by comparing the population,
experimental intervention and control intervention. We assessed
statistical heterogeneity in the included trials both by visual
inspection of a forest plot, and by using a standard Chi2 test value
with a significance level of P = 0.10. We assessed heterogeneity by
using the I2 statistic. We interpreted an I2 statistic value of ≥ 50%
with a statistically significant value for the Chi2 test as evidence of
substantial statistical heterogeneity (Higgins 2011b).
Assessment of reporting biases
There was an insuEicient number of trials to assess reporting bias
using either funnels plot or the Egger test for any of the stated
outcomes (Egger 1997; Higgins 2011b).
Data synthesis
We performed data synthesis according to recommendations in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011b), using Review Manager 2014 for statistical analysis and
trial sequential analysis (TSA) for explorative reasons (Thorlund
2011). We undertook random-eEects meta-analysis except where
there was evidence of substantial statistical heterogeneity and both
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random-eEects and fixed-eEect models were reported (Deeks 2011;
Demets 1987; DerSimonian 1986). Given the range of instruments
and outcome domains, we did not undertake a meta-analysis of
health-related quality of life outcomes; we presented a narrative
summary instead.
TSA
For explorative reasons we undertook TSA to assess the risk of
random errors, because cumulative meta-analyses are at risk of
producing random errors due to sparse data and repetitive testing
on the accumulating data (Thorlund 2009; Thorlund 2011; TSA
2011; Wetterslev 2008). The underlying assumption of TSA is that
testing for significance may be performed each time a new trial
is added to the meta-analysis. We added the trials according to
their year of publication and, if more than one trial had been
published in a year, we added trials alphabetically according to the
last name of the first author (Wetterslev 2008). To minimise random
errors, we calculated the required information size (that is, the
number of participants needed in a meta-analysis to detect or reject
a certain intervention eEect) (Wetterslev 2008). The information
size calculation also accounted for the heterogeneity or diversity
present in the meta analysis (Wetterslev 2009).
We based the required information size for dichotomous outcomes
on the assumption of a plausible RR reduction of 20% from
the proportion with the outcome in the control group, or on
the RR reduction observed in the included trials at low risk of
bias (Wetterslev 2008). For continuous outcomes, we tested for a
diEerence of 0.5 SD using the SD from the control groups. As a
default, we used a type I error of 5%, a type II error of 20%, and
diversity of 30% and 60%, or as suggested by the trials in the meta-
analysis (Wetterslev 2008; Wetterslev 2009).
Trial sequential monitoring boundaries can be constructed on
the basis of the required information size and the risks for type
I (5%) and type II (20%) errors (Thorlund 2011; Wetterslev 2008).
These boundaries will determine the statistical inference that
can be drawn regarding the cumulative meta-analysis that has
not reached the required information size: if the trial sequential
monitoring boundary is crossed before the required information
size is reached, it is possible that firm evidence may be established
and further trials may turn out to be superfluous. On the other
hand, if the boundary is not surpassed, it is probably necessary
to continue conducting trials in order to detect or reject a certain
intervention eEect.
Subgroup analysis and investigation of heterogeneity
There were insuEicient data to undertake the following subgroup
analyses for the primary outcomes using stratified meta-analysis or
meta-regression.
• Trials at overall low risk of bias compared with trials at overall
high risk of bias; if we did not categorise any trials as being
at overall low risk of bias, we planned to perform sensitivity
analysis on trials at overall lower risk of bias compared to trials
at overall higher risk of bias.• Trials in the primary prevention ICD population versus
secondary prevention ICD populations.• Trials including women only versus trials including men only.• Trials including younger participants (defined according to the
trial authors as, for example, under 60 years) only versus trials
including older participants (defined according to the trial
authors as, for example, over 60 years) only.• Trials including only ICD participants compared to trials
with mixed participant populations (both ICD and non-ICD
participants).• Trials with high compliance in the intervention groups (defined
according to the trial authors) compared to trials with low
compliance in the intervention groups (defined according to the
trial authors).
But there were suEicient data to perform the following subgroup
analyses.
• Trials with a short follow-up period (end of intervention) versus
trials with a longer follow-up period (longest available follow-
up).• Trials with an exercise intervention only compared to trials with
an exercise intervention plus any other co-intervention, such as
a psychoeducational intervention.
Sensitivity analysis
Without individual patient data, it was not possible to consider the
impact of loss to follow-up on the continuous outcome of health-
related quality of life. Therefore we limited our sensitivity analyses
to the primary outcomes of all-cause mortality and serious adverse
events, based on the information provided on losses for follow-up.
Best-worse case scenario
For the best-worst case analysis, we assumed that all participants
lost to follow-up in the exercise-based cardiac rehabilitation group
had not experienced the outcome, and all those with missing
outcomes in the control group had experienced the outcome.
Worst-best case scenario
For the worst-best case analysis, we assumed that all participants
lost to follow-up in the exercise-based cardiac rehabilitation group
had experienced the outcome, and all those with missing outcomes
in the control group had not experienced the outcome
Summary of findings
Two review authors (KMN and SKB) created 'Summary of
findings' tables using the following outcomes: all-cause mortality,
serious adverse events, health-related quality of life, exercise-
capacity, antitachycardia pacing, and ICD shock. We developed
two 'Summary of findings' tables, one for each time point that
outcomes were assessed. We used the five GRADE considerations
(study limitations, consistency of eEect, imprecision, indirectness,
and publication bias) to assess the quality of the body of evidence
supporting each of the listed outcomes. We used methods and
recommendations described in Section 8.5 and Chapter 12 of the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011a), using GRADEpro soJware (gradepro.org). We justified all
decisions to downgrade the quality of studies using footnotes.
Please see Summary of findings for the main comparison for results
at end of intervention and Summary of findings 2 for results at
longest available follow-up.
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R E S U L T S
Description of studies
The selection process is summarised in the PRISMA flowchart
shown in Figure 1, Characteristics of included studies,
Characteristics of excluded studies, and Characteristics of studies
awaiting classification.
Results of the search
The electronic searches yielded a total of 2601 titles aJer de-
duplication. AJer reviewing titles and abstracts, we obtained 30
full text papers for possible inclusion. AJer reviewing the texts, we
included eight RCTs published in 16 publications.
Included studies
The included trials randomised a total of 1730 ICD participants
with or without cardiac resynchronisation therapy (CRT) function
to exercise-based cardiac rehabilitation or control. The majority
of the trials were small (7 trials < 200 patients) and single
centre (6 trials) with one large trial contributing about 61%
(1053 participants) of all the included participants (Piccini 2013).
Participants were predominantly male with heart failure and the
mean age of participants across the included trials ranged from
54 to 65 years. Only two trials reported on ethnicity and 69% to
84% of the study population was white (Dougherty 2015; Piccini
2013). The percentage of included patients with heart failure
ranged from 76.8% to 100% (exercise group) and 75.3% to 100%
(control group). All trials assessed the eEects of physical exercise
training as the experimental intervention and two trials used
psychoeducation in addition to the physical exercise training,
but only in the experimental intervention group (Berg 2014;
Frizelle 2004). Exercise-based-cardiac rehabilitation programmes
were mostly delivered by a combination of centre-based setting
and home exercise sessions. The dose of exercise training ranged
widely across the eight trials with two to seven sessions per week
with session duration of 10 to 60 minutes for a period of eight to 26
weeks. In one trial the control group were asked not to start a new
exercise programme (Dougherty 2015). The rest of the trials either
did not report on this or the control group had no restriction in
activity. None of the trials reported any data on the control groups.
All trials reported that exercise-based cardiac rehabilitation was
safe with no ICD shocks during exercise. Three trials reported ICD
settings and all three trials reported that the defibrillator discharge
threshold was set 20 beat per minute higher than maximal training
heart rate (Belardinelli 2006; Dougherty 2015; Piotrowicz 2015). The
reported follow-up on the primary outcome ranged from the end
of the intervention to the longest follow-up of 45 months, with
a median follow-up of 18 months. Only the trials of Belardinelli
2006 and Frizelle 2004 did not report on funding nor their potential
conflicts of interest.
Details for each of the specific trials included in the review are
shown in the 'Characteristics of included studies' table.
Studies awaiting classification
Two studies are awaiting classification. The reasons for this
are presented in the section 'Characteristics of studies awaiting
classification'.
Excluded studies
We excluded 11 studies.The reasons for this are presented in the
section 'Characteristics of excluded studies'.
Ongoing studies
One study was an ongoing study and is presented in the section
'Characteristics of ongoing studies'.
Risk of bias in included studies
Risk of bias assessments are summarised in Figure 2 and Figure
3. Many trials failed to give suEicient detail to enable a clear
assessment of their potential risk of bias. Based on the information
available, we classified all trials as having an overall high risk of
bias.
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Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
 
Allocation
Random sequence generation
In the randomisation process, three trials had a low risk of bias
as they used either a computer random-number generator or a
table of random numbers (Berg 2014; Dougherty 2015; Piotrowicz
2015). One trial also used a table of random numbers, but there
were 30 patients in the intervention group and only 22 patients in
the control group, and we therefore marked the trial as unclear
risk of bias (Belardinelli 2006). Three trials had an unclear risk of
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bias because of insuEicient details (Frizelle 2004; Smolis-Bak 2015;
Smolis-Bak 2017), and one trial had a high risk of bias because
it was a subgroup analysis of a larger trial including heart failure
patients (Piccini 2013).
Allocation concealment
In the concealment process, three trials had a low risk of bias as they
used either an independent randomisation unit or an interactive
voice response (Berg 2014; Dougherty 2015; Piccini 2013). Five
trials had an unclear risk of bias because of insuEicient reporting
(Belardinelli 2006; Frizelle 2004; Piotrowicz 2015; Smolis-Bak 2015;
Smolis-Bak 2017).
Blinding
Given the nature of cardiac rehabilitation, we judged all trials to be
of high risk given the lack of blinding of participants and personnel.
Blinding of outcome assessment was only reported in two trials
(Berg 2014; Dougherty 2015). Berg 2014 had a low risk bias as
the outcome assessment was blinded and Dougherty 2015 had an
unclear risk of bias as the statistician was not blinded to the group
assignment.
Incomplete outcome data
The number of and reasons for dropouts and withdrawals was fully
described in four trials (Berg 2014; Dougherty 2015; Frizelle 2004;
Piotrowicz 2015). Four trials did not provide any information about
dropouts and withdrawals and were therefore marked as unclear
risk (Belardinelli 2006; Piccini 2013; Smolis-Bak 2015; Smolis-Bak
2017).
Selective reporting
Two trials reported all outcomes reported in their protocol
publication and therefore we marked them as low risk (Berg 2014;
Dougherty 2015). All intended outcomes for Frizelle 2004 and
Smolis-Bak 2015 were reported as stated in the objectives of the
trial, but we did not identify any published protocols for the trials
to confirm this, and we therefore marked them as unclear risk. The
trial of Belardinelli 2006 did not have a published design paper,
there was no hierarchy of outcomes and there was no sample
size calculation. The trial of Piotrowicz 2015 did not report on leJ
ventricular ejection fraction (LVEF) aJer intervention as described
in the methods section. We therefore marked both trials as high
risk.
Other potential sources of bias
Performance bias
Two trials reported that they had no co-interventions (Dougherty
2015; Piotrowicz 2015) and one trial reported that both groups
received guidelines on a healthy lifestyle (physical activity,diet)
(Smolis-Bak 2017), therefore we marked them as low risk.
The remaining trials either did not report any co-intervention
(Belardinelli 2006; Frizelle 2004; Piccini 2013; Smolis-Bak 2015) or
the control group were not denied to receive rehabilitation at a local
hospital (Berg 2014), therefore we marked them as unclear risk.
Groups balanced at baseline
We assessed five trials to be comparable in regards to the
characteristics of the participants before the start of the
intervention in the intervention/control groups and therefore we
marked them as low risk of bias (Berg 2014; Dougherty 2015; Frizelle
2004; Piccini 2013; Smolis-Bak 2017). We assessed two trials to be
not comparable because of a large age diEerence in the cardiac
rehabilitation and control groups and therefore we marked them as
high risk of bias (Piotrowicz 2015; Smolis-Bak 2015). We assessed
one trial to be comparable in regards to the characteristics of the
participants, but because of an unequal randomisation with 30
participants in the exercise-based cardiac rehabilitation group and
only 22 participants in the control group we marked it as unclear
risk of bias (Belardinelli 2006).
Intention-to-treat analysis
All trials conducted the analyses according to an intention-to-
treat analysis and therefore we marked them as low risk of bias
(Belardinelli 2006; Berg 2014; Dougherty 2015; Frizelle 2004; Piccini
2013; Piotrowicz 2015; Smolis-Bak 2015; Smolis-Bak 2017).
For-profit bias
Six trials reported their sources of funding (Berg 2014; Dougherty
2015; Piccini 2013; Piotrowicz 2015; Smolis-Bak 2015; Smolis-Bak
2017). Berg 2014 was funded by several foundations, none of
which had any conflicts of interest in the trial. Dougherty 2015
was funded by the National Institutes of Health, National Heart,
Lung, and Blood Institute. Piccini 2013 was founded by several
grants, e.g. from companies that produce ICDs. Piotrowicz 2015
was funded by the National Science Centre, Poland. Smolis-Bak
2015 and Smolis-Bak 2017 were funded by the State Committee for
Scientific Research. The rest of the included trials did not report on
their source of funding (Belardinelli 2006; Frizelle 2004).
Overall risk of bias
We judged all of the included trials and outcome results at an
overall high risk of bias as we judged all of the trials to be 'unclear'
or ‘high risk’ in one or more risk of bias domains.
E;ects of interventions
See: Summary of findings for the main comparison Exercise
compared to no exercise at the end of the intervention for
adults with an implantable cardioverter defibrillator; Summary of
findings 2 Exercise compared to no exercise at longest available
follow-up for adults with an implantable cardioverter defibrillator
See: Summary of findings for the main comparison for results at the
end of the intervention and Summary of findings 2 for results at the
longest available follow-up.
Primary outcomes
All-cause mortality
Meta-analysis
End of the intervention
Seven trials with a total of 677 participants and a follow-up
ranging from eight weeks to 24 weeks reported all-cause mortality
(Belardinelli 2006; Berg 2014; Dougherty 2015; Frizelle 2004; Smolis-
Bak 2015; Piotrowicz 2015; Smolis-Bak 2017). Six trials reported no
deaths and one trial reported a total of three deaths (exercise-based
cardiac rehabilitation: 2 deaths; control: 1 death). One trial reported
a combined endpoint of shock and death with 176 events in the
exercise-based cardiac rehabilitation group and 177 events in the
control group (Piccini 2013). As only one trial reported results at
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the end of the intervention, it was not possible to perform a meta-
analysis. Instead we have reported on a single study result, with
no evidence of a diEerence between the exercise-based cardiac
rehabilitation group and the control group at the end of the
intervention (risk ratio (RR) 1.96, 95% confidence interval (CI) 0.18
to 21.26; quality of evidence: low; Analysis 1.1).
Longest available follow-up aJer the intervention period
Four trials with a total of 384 participants and a follow-up
ranging from 12 months to 45 months reported all-cause mortality
(Belardinelli 2006; Berg 2014; Smolis-Bak 2015; Smolis-Bak 2017).
One trial reported no deaths and three trials reported a total of
46 deaths (exercise-based cardiac rehabilitation: 25 deaths; control
21 deaths). Meta-analysis showed that there was no evidence of a
diEerence between the exercise-based cardiac rehabilitation group
and control group at longest available follow-up (RR 1.18, 95% CI
0.65 to 2.14; quality of evidence: very low; Analysis 4.1).
Heterogeneity
End of intervention
We were unable to test for statistical heterogeneity as only one trial
reported deaths.
Longest available follow-up aJer the intervention period
Neither visual inspection of the forest plots nor tests for
statistical heterogeneity (I2 = 7%; P = 0.34) indicated evidence of
heterogeneity.
Sensitivity analyses
End of the intervention
The best-worst case meta-analysis (RR 0.07, 95% CI 0.02 to
0.22; Analysis 2.1) showed that incomplete outcome data bias
might potentially influence the results. The worst-best case meta-
analyses in a random-eEects model (RR 13.50, 95% CI 3.24 to 56.25;
Analysis 3.1) showed that incomplete outcome data bias would
not influence the results, but in a fixed-eEect model the meta-
analyses (RR 16.78, 95% CI 4.32 to 65.18; Analysis 3.2) showed
that incomplete outcome data bias might potentially influence the
results.
Visual inspection of the forest plots showed no signs of
heterogeneity in a best-worst case scenario. In a worst-best case
scenario visual inspection of the forest plots showed that the
Frizelle 2004 trial compared to the remaining trials seemed to have
an extreme result favouring exercise-based cardiac rehabilitation
and the test for statistical heterogeneity was also significant (I2 =
56%; P = 0.08). A post hoc sensitivity analysis showed that the meta-
analysis result was not changed significantly when removing the
trial of Frizelle 2004 from the analysis (RR 13.50, 95% CI 3.24 to
56.25; Analysis 3.3).
Longest available follow-up aJer the intervention period
Both the best-worst case meta-analysis (RR 0.48, 95% CI 0.32 to
0.74; Analysis 5.1) and the worst-best case meta-analysis (RR 2.29,
95% CI 1.12 to 4.70; Analysis 6.1) showed that incomplete outcome
data bias might potentially influence the results.
Subgroup analysis
It was only possible to conduct one subgroup analysis because
there were no relevant data for the remaining planned subgroup
analyses.
Test for subgroup diEerences showed no evidence of a
diEerence in the subgroup analysis of exercise-based cardiac
rehabilitation intervention only compared to exercise-based
cardiac rehabilitation intervention plus any other co-intervention
at longest follow-up, P = 0.60; Analysis 7.1).
Assessment of clinical significance
We did not assess the clinical significance of the results on all-
cause mortality as the thresholds for statistical significance were
not crossed at either end of the intervention or at longest available
follow-up aJer the intervention period.
Serious adverse events
Meta-analysis
End of intervention
Three trials with a total of 467 participants and a follow-up ranging
from eight weeks to 24 weeks reported results on serious adverse
events (Berg 2014; Dougherty 2015; Piotrowicz 2015). FiJy-two
exercise-based exercise-based cardiac rehabilitation participants
experienced one or more serious adverse event compared with 48
control participants. Only the trials of Berg 2014 and Dougherty
2015 contributed to this meta-analysis as the third study had no
events. Meta-analysis of these two trials (356 participants) showed
no evidence of a diEerence (RR 1.05, 95% CI 0.77 to 1.44; quality of
evidence: low; Analysis 1.2). See Figure 4 for a detailed description
of the serious adverse events.
 
Figure 4.   Table: Serious adverse events at end of intervention.
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Longest available follow-up aJer the intervention period
Three trials with a total of 188 participants and a follow-up
ranging from 12 months to 18 months reported results on serious
adverse events (Belardinelli 2006; Smolis-Bak 2015; Smolis-Bak
2017). Fourteen exercise-based cardiac rehabilitation participants
experienced one or more serious adverse event compared with
23 control participants. Meta-analysis showed no evidence of a
diEerence using a random-eEects model (RR 0.84, 95% CI 0.43 to
1.65; quality of evidence: very low; Analysis 4.2). Using a fixed-
eEect model there was evidence of a diEerence favouring exercise-
based cardiac rehabilitation (RR 0.81, 95% CI 0.61 to 1.08; quality of
evidence: very low; Analysis 4.3). We have chosen to use the result
from the fixed-eEect model, as it was the most conservative result.
See Figure 5 for a detailed description of the serious adverse events.
 
Figure 5.   Table: Serious adverse events at longest available follow-up.
 
Heterogeneity
End of intervention
Neither visual inspection of the forest plots nor tests for
statistical heterogeneity (I2 = 0%; P = 0.67) indicated evidence of
heterogeneity.
Longest available follow-up aJer the intervention period
Both visual inspection of the forest plots and tests for
statistical heterogeneity (I2 = 69%; P = 0.04) indicated substantial
heterogeneity. A post hoc sensitivity analysis showed that the meta-
analysis result was not changed significantly when removing the
trial of Belardinelli 2006 from the analysis (RR 1.01, 95% CI 0.76 to
1.34; I2 = 0%, P = 0.70).
Sensitivity analyses
End of intervention
The best-worst case meta-analysis (RR 0.58, 95% CI 0.41 to 0.82;
Analysis 2.2) and worst-best case meta-analysis (RR 1.74, 95% CI
1.34 to 2.27; Analysis 3.4) showed that incomplete outcome data
bias might potentially influence the results.
Visual inspection of the forest plots showed no signs of
heterogeneity.
Longest available follow-up aJer the intervention period
Two of the three trials did not report any dropouts and we were
therefore unable to perform sensitivity analyses.
Subgroup analysis
It was only possible to conduct two subgroup analyses because
there were no relevant data for the remaining planned subgroup
analyses.
The test for subgroup diEerences showed no evidence of a
diEerence in the subgroup analyses for trials with a short follow-up
period compared to trials with a longer follow-up period, P = 0.56;
Analysis 7.2. The test for subgroup diEerences showed no evidence
of a diEerence in the subgroup analyses for trials with an exercise
intervention only compared to trials with an exercise intervention
plus any other co-intervention at the end of the intervention, P =
0.67; Analysis 7.3.
Assessment of clinical significance
We did not assess the clinical significance of the results on serious
adverse events as the thresholds for statistical significance was not
crossed at either end of the intervention or at longest available
follow-up aJer the intervention period.
Health-related quality of life
End of the intervention
Five trials with a total of 433 participants and a follow-up ranging
from eight weeks to 24 weeks reported results on health-related
quality of life (Belardinelli 2006; Berg 2014; Frizelle 2004; Piotrowicz
2015; Smolis-Bak 2015); results are summarised in Figure 6.
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Figure 6.   Summary of results on health related quality of life at end of intervention and at longest available follow-
up
 
Two of the five trials reported the SF-36 (Berg 2014; Piotrowicz
2015). Berg 2014 showed evidence of a greater improvement in
the exercise-based cardiac rehabilitation group than control group
on SF-36 Mental Component Score but no diEerence in Physical
Component Score. Piotrowicz 2015 showed no evidence of a
diEerence between total SF-36 score. It was not possible to conduct
a meta-analysis on the two trials as Piotrowicz 2015 used a Polish
version of the SF-36 and therefore was not comparable to Berg
2014, who used the original validated version of SF-36.
Smolis-Bak 2015 reported no evidence of a diEerence between the
exercise-based cardiac rehabilitation and control groups on the
total Nottingham Health Profile score (Smolis-Bak 2015). Only this
trial used the Nottingham Health Profile and meta-analysis was
therefore not possible.
Frizelle 2004 reported no evidence of a diEerence between
the exercise-based cardiac rehabilitation and control groups on
EuroQol score (Frizelle 2004). Only this trial used the EuroQual and
meta-analysis was therefore not possible.
Belardinelli 2006 reported no evidence of a diEerence between
the exercise-based cardiac rehabilitation and control groups
on Minnesota Living with Heart Failure Questionnaire Physical,
Emotional or Socio-Economic subscores (Belardinelli 2006).
Only this trial used the Minnesota Living with Heart Failure
Questionnaire and meta-analysis was therefore not possible.
Longest available follow-up aJer the intervention period
One trial with a total of 52 participants reported results on health-
related quality of life at 12 months of follow-up with no evidence
of a diEerence between the exercise-based cardiac rehabilitation
and control groups on the total Nottingham Health Profile score
(Smolis-Bak 2015). Only this trial reported results at longest follow-
up and meta-analysis was therefore not possible.
Assessment of clinical significance
It was not possible to asses the clinical significance of the
results on health-related quality of life. The included trials used
diEerent health-related quality of life measures and calculating
the minimally important diEerence in health-related quality of life
measures is debated (Farivar 2004). Some suggest that this can
be done using 0.5 SD and some argue that using 0.3 SD is more
accurate. However, no consensus on recommendations exist.
Secondary outcomes
Exercise-capacity at the end of the intervention
Meta-analysis
End of the intervention
Eight trials with a total of 1507 participants and a follow-up ranging
from eight weeks to 24 weeks reported results on exercise-capacity.
Seven trials reported VO2 peak with a total of 1485 participants
(Belardinelli 2006; Berg 2014; Dougherty 2015; Piccini 2013;
Piotrowicz 2015; Smolis-Bak 2015; Smolis-Bak 2017). Random-
eEects meta-analysis showed evidence of a higher VO2 peak with
exercise-based cardiac rehabilitation compared with control at the
end of the intervention (mean diEerence (MD) 2.27, 95% CI 1.07 to
3.46, quality of evidence: very low; Analysis 1.3). Using a fixed-eEect
model there was evidence of a diEerence favouring exercise-based
cardiac rehabilitation compared to control (MD 0.91, 95% CI 0.60 to
1.21, quality of evidence: very low; Analysis 1.4). We have chosen
to use the result from the fixed-eEect model, as it was the most
conservative result.
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Consistent with this, Frizelle 2004 reported evidence of a greater
improvement in mean shuttle test distance from baseline in the
exercise-based cardiac rehabilitation group compared with control
group (exercise-based cardiac rehabilitation group: mean changes
85.56, SD 24.13; control group: mean changes 0.32) (Frizelle 2004).
Only this trial used the shuttle test and meta-analysis was therefore
not possible.
Longest available follow-up aJer the intervention period
Two trials with a total of 136 participants reported results on
exercise-capacity at 12 months of follow-up with no evidence of a
diEerence between the exercise-based cardiac rehabilitation and
control groups (MD 0.83, 95% CI -0.66 to 2.32, quality of evidence:
very low; Analysis 4.4) (Smolis-Bak 2015; Smolis-Bak 2017).
Heterogeneity
End of intervention
Visual inspection of the forest plot did not show any clear signs of
heterogeneity. However tests for statistical heterogeneity indicated
evidence of heterogeneity (I2 = 79%; P = 0.0002).
Longest available follow-up aJer the intervention period
Both visual inspection of the forest plots and tests for statistical
heterogeneity (I2 = 89%; P = 0.002) indicated substantial
heterogeneity. A post hoc sensitivity analysis was not possible as
there were only two trials.
Assessment of clinical significance
Our results show that exercise-based cardiac rehabilitation might
increase the exercise-capacity in adults with an ICD at the end of the
intervention. However, exercise-capacity is a surrogate outcome
with questionable clinical relevance, so the clinical significance of
this outcome result should be interpreted with caution. Further,
based on prior studies a 6% change in peak VO2 has shown to be
clinically meaningful in heart failure patients (Corrá 2006).
ICD antitachycardia pacing
Meta-analysis
End of the intervention
Two trials with a total of 356 participants and a follow-
up ranging from 12 weeks to 24 weeks reported results on
antitachycardia pacing (Berg 2014; Dougherty 2015). Thirty-eight
exercise-based cardiac rehabilitation participants experienced one
or more antitachycardia pacing event(s) compared with 29 control
participants. Meta-analysis showed no evidence of a diEerence (RR
1.26, 95% CI 0.84 to 1.90; quality of evidence: moderate; Analysis
1.5).
Longest available follow-up aJer the intervention period
One trial with a total of 196 participants reported results on
antitachycardia pacing at 45 months of follow-up with no evidence
of a diEerence between the exercise-based cardiac rehabilitation
and control groups (Berg 2014). Only this trial reported results at
longest follow-up and meta-analysis was therefore not possible.
Heterogeneity
End of intervention
Neither visual inspection of the forest plots nor tests for
statistical heterogeneity (I2 = 0%; P = 0.66) indicated evidence of
heterogeneity.
Longest available follow-up aJer the intervention period
We were unable to test for statistical heterogeneity as only one trial
reported antitachycardia pacing.
Assessment of clinical significance
The clinical significance of the results for antitachycardia pacing
was unclear. The outcome results should be interpreted with
caution as we assessed them as high risk of bias and the lack
of statistical significance may very well be due to random error
and lack of power. But as there was no diEerence in the risk
of requiring antitachycardia pacing between the exercise-based
cardiac rehabilitation group and the control group at the end
of the intervention, one could argue, that exercise-based cardiac
rehabilitation was safe, as it did not increase ventricular heart
activity as this would have let to an increase of antitachycardia
pacing.
ICD shock
Meta-analysis
End of the intervention
Three trials with a total of 428 participants and a follow-up ranging
from eight weeks to 24 weeks reported results on appropriate shock
(Berg 2014; Dougherty 2015; Piotrowicz 2015). Thirty-one exercise-
based cardiac rehabilitation participants experienced one or more
appropriate shocks compared with 25 control participants. Meta-
analysis showed no evidence of a diEerence (RR 0.56, 95% CI 0.20
to 1.58; quality of evidence: low; Analysis 1.6).
Two trials with a total of 234 participants and a follow-up ranging
from eight weeks to 24 weeks reported results on inappropriate
shock (Dougherty 2015; Piotrowicz 2015). One trial reported no
inappropriate shock and one trial reported a total of three
inappropriate shocks (exercise-based cardiac rehabilitation: 1
inappropriate shock; control: 2 inappropriate shocks). As only one
trial reported results at the end of the intervention we were unable
to conduct a meta-analysis. Instead we have reported on a single
study result, with no evidence of a diEerence between the exercise-
based cardiac rehabilitation group and control group at the end of
the intervention (RR 0.60, 95% CI 0.10 to 3.51; quality of evidence:
moderate; Analysis 1.7).
Longest available follow-up aJer the intervention period
Four trials with a total of 384 participants and a follow-up ranging
from 12 months to 45 months reported results on appropriate
shock (Belardinelli 2006; Berg 2014; Smolis-Bak 2015; Smolis-Bak
2017). Sixty-one exercise-based cardiac rehabilitation participants
experienced one or more appropriate shock(s) compared with
67 control participants. Meta-analysis showed no evidence of a
diEerence using neither a random-eEects model (RR 0.28, 95% CI
0.05 to 1.65; quality of evidence: very low; Analysis 4.5) nor a fixed-
eEect model (RR 0.88, 95% CI 0.68 to 1.13; quality of evidence:
very low; Analysis 4.6). We have chosen to use the result from the
random-eEects model, as it was the most conservative result.
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One trial with a total of 1053 participants and a follow-up of 26
months reported results on all shock (Piccini 2013). One hundred
and eight exercise-based cardiac rehabilitation participants
experienced one or more appropriate shock(s) compared with 113
control participants. As only one trial reported results at longest
available follow-up aJer the intervention period we were unable
to perform a meta-analysis. Instead we have reported on a single
study result, with no evidence of a diEerence between the exercise-
based cardiac rehabilitation group and control group at longest
available follow-up aJer the intervention period (RR 0.89, 95% CI
0.70 to 1.12; quality of evidence: very low; Analysis 4.7).
Heterogeneity
End of intervention
Neither visual inspection of the forest plots nor tests for
statistical heterogeneity (I2 = 43%; P = 0.17) indicated evidence of
heterogeneity for results on appropriate shock.
We were unable to test for statistical heterogeneity as only one trial
reported on inappropriate shock.
Longest available follow-up aJer the intervention period
Both visual inspection of the forest plots and tests for statistical
heterogeneity (I2 = 77%; P = 0.004) indicated evidence of
heterogeneity for results on appropriate shock.
We were unable to test for statistical heterogeneity as only one trial
reported on all shocks.
Assessment of clinical significance
The clinical significance of the results on appropriate shock,
inappropriate shock and all shocks was unclear. Outcome results
should be interpreted with caution as the 95% Cl was very wide
and we could not rule out any beneficial or harmful eEects at this
time. But as there was no diEerence in the risk of requiring an ICD
shock between the exercise-based cardiac rehabilitation group and
the control group, neither at end of intervention nor at longest
available follow-up aJer the intervention period, one could argue,
that exercise-based cardiac rehabilitation was safe, as it did not
increase ventricular heart activity as this would have led to an
increase of ICD shock.
Non-serious adverse events
Meta-analysis
End of the intervention
Two trials with a total of 271 participants and a follow-up ranging
from eight weeks to 24 weeks reported results on the proportion
of participants with non-serious adverse events at the end of the
intervention (Dougherty 2015; Piotrowicz 2015). Eleven exercise-
based cardiac rehabilitation participants experienced one or more
serious adverse event compared with one control participants.
Meta-analysis showed some evidence of a diEerence favouring the
control group (RR 5.44, 95% CI 1.01 to 29.32; Analysis 1.8), but the
extremely wide Cls, with the lower CI very close to one, suggested
that the data are compatible with their being no diEerence between
groups.
Longest available follow-up aJer the intervention period
No trials reported results on non-serious adverse events aJer the
end of the intervention.
Heterogeneity
End of the intervention
Neither visual inspection of the forest plots nor tests for
statistical heterogeneity (I2 = 0%; P = 0.80) indicated evidence of
heterogeneity.
Assessment of clinical significance
The clinical significance of the results on non-serious adverse
events was sparse, as only two trials, with a total of 271 participants,
reported on this outcome.
Employment
Meta-analysis
End of intervention
None of the included trials reported on this outcome at the end of
the intervention.
Longest available follow-up aJer the intervention period
Only one trial reported results at 12 months of follow-up, and
therefore we were unable to perform a meta-analysis. Instead, we
have reported on a single trial result, which showed that aJer one
year, 81% of the patients working before ICD implantation were still
employed with no evidence of a diEerence between the exercise-
based cardiac rehabilitation group and control group (Berg 2014).
Assessment of clinical significance
We did not assess the clinical significance of the results on
employment as only one trial reported on this outcome.
Costs and cost-e+ectiveness
Meta-analysis
End of intervention
None of the included trials reported on this outcome at the end of
the intervention.
Longest available follow-up aJer the intervention period
Only one trial reported results at 45 months of follow-up, and
therefore we were unable to perform a meta-analysis. Instead,
we have reported on a single study result, which showed that
the rehabilitation programme resulted in a reduction in total
attributable direct healthcare costs at 36 months' follow-up. The
cost of rehabilitation was USD 335/EUR 276 per patient enrolled
in rehabilitation. The total attributable cost of rehabilitation aJer
three years was – USD 6789/- EUR 5593 in favour of exercise-based
cardiac rehabilitation (Berg 2014). Only this trial reported results
and we were therefore unable to perform a meta-analysis.
Assessment of clinical significance
We did not assess the clinical significance of the results on costs and
cost-eEectiveness as only one trial reported on this outcome.
D I S C U S S I O N
Summary of main results
This systematic review identified eight randomised controlled trials
(RCTs) with a total of 1730 participants, with an implantable cardiac
device (ICD) with or without cardiac resynchronisation therapy
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(CRT) function, comparing exercise-based cardiac rehabilitation
with no exercise control. All trials and outcome results were at
high risk of bias and we assessed the evidence for all outcomes as
ranging from very low to moderate quality.
The exercise-based programmes consisted in all eight trials of both
aerobic exercise and resistance training or stretching (Belardinelli
2006; Berg 2014; Dougherty 2015; Frizelle 2004; Piccini 2013;
Piotrowicz 2015; Smolis-Bak 2015; Smolis-Bak 2017). The dose of
exercise training ranged widely across the trials with two to seven
sessions per week and a duration of 10 to 60 minutes per session
for a period of eight to 26 weeks. In two trials, the exercise-based
programme was supplemented by psychoeducational follow-up,
either face-to-face or by phone (Berg 2014; Frizelle 2004).
The trials had diEerent approaches to their control group. One trial
asked the control group not to start a new exercise programme
(Dougherty 2015). The rest of the trials either did not report on
this or the control group had no restriction in activity. None of the
trials reported any data on the control groups, why we grouped the
control groups into a single control throughout the review.
Meta-analysis showed that there was no evidence of a diEerence
in all-cause mortality at the end of the intervention or at
the longest available follow-up. There was also no evidence of
a diEerence in serious adverse events between exercise-based
cardiac rehabilitation and control at the end of the intervention
or at the longest available follow-up. Sensitivity analysis showed
that incomplete outcome data bias might potentially influence
the results of both all-cause mortality and serious adverse events.
Tests for subgroup diEerences showed no evidence of a diEerence
in trials with a short follow-up period compared to trials with a
longer follow-up period, or trials with an exercise intervention only
compared to trials with an exercise intervention plus any other co-
intervention at the end of the intervention, and at longest available
follow-up aJer the intervention period. Given the variation in
reported health-related quality of life outcomes, it was not possible
to pool data. The five trials reporting health-related quality of life,
showed little or no diEerence at follow-up between exercise-based
cardiac rehabilitation and control.
For secondary outcomes, this systematic review demonstrates a
potential positive eEect of exercise-based cardiac rehabilitation
on exercise capacity compared to control at the end of the
intervention. However, these eEects of exercise-based cardiac
rehabilitation are more uncertain at longest available follow-
up aJer the intervention period. This systematic review also
demonstrates that there are uncertain eEects of exercise-based
cardiac rehabilitation on antitachycardia pacing, appropriate
shock, inappropriate shock, all shock, non-serious adverse events,
employment and cost-eEectiveness at the end of the intervention
and at longest available follow-up aJer the intervention period.
This systematic review demonstrates that exercise-based cardiac
rehabilitation might improve short-term exercise capacity
compared with control. However, given the lack of evidence it
was not possible to definitively assess the eEects of exercise-
based cardiac rehabilitation on all-cause mortality, serious adverse
events, or health-related quality of life. All trials were at high risk of
bias so it is highly likely that our results overestimate benefit and
underestimate harm.
Our results are summarised in Summary of findings for the main
comparison for results at the end of the intervention and Summary
of findings 2 for results at longest available follow-up.
Overall completeness and applicability of evidence
We searched for RCTs irrespective of language, publication
year, publication type and publication status. We also searched
ClinicalTrials.gov, Controlled-trials.com, and The World Health
Organization International Clinical Trials Registry Platform to
search for ongoing trials or any that had not yet been published.
There was an insuEicient number of trials to assess reporting bias
using funnel plots for any of the stated outcomes.
When analysing the eEects of exercise-based cardiac rehabilitation
on all-cause mortality and serious adverse events, tests were
limited to two subgroup analyses: trials with a short follow-up
period compared to trials with a longer follow-up period; and trials
with exercise intervention only compared to trials with exercise
intervention plus any other co-intervention.
Our analyses showed that there was only evidence of a diEerence
favouring exercise-based cardiac rehabilitation, when it comes to
the outcome, exercise capacity. However, this finding needs to
be interpreted with caution as all trials had a high risk of bias.
Exercise-based cardiac rehabilitation might improve short-term
exercise capacity compared with control, but there was no evidence
of a long-term improvement. This could indicate that exercise-
based cardiac rehabilitation did not have any permanent change in
exercise behaviour in the included participants and therefore did
not have a deferred benefit.
Quality of the evidence
We used the GRADE approach to assess the quality of evidence
of each outcome result (Guyatt 2008). The GRADE assessments
showed that the quality of evidence ranged from very low quality
to moderate quality. Accordingly, there is a high risk that future
trials may overturn the results of this present review. Reasons for
the GRADE assessments are given below and are also described in
the footnotes of Summary of findings for the main comparison for
results at the end of the intervention and of Summary of findings 2
for results at the longest available follow-up.
The lack and quality of the reporting of methods in the majority
of included trials made it diEicult to assess their risk of bias. This
was especially evident in terms of selection bias, performance bias,
detection bias, and other bias. We judged the overall risk of bias
in all the trials to be ‘high risk’, as we judged all of the trials to be
'unclear' or ‘high risk’ in one or more risk of bias domains. Two trials
described their methodology in more depth and if we disregarded
the bias domain of blinding of participants and personnel, these
trails would have a low risk of bias. We assessed the risk of bias as
high and downgraded these results by one level if 50% or lower of
the included trials had a high risk of bias, and two levels if more than
50% of the included trials had a high risk of bias. For a summary on
risk of bias, see Figure 2 and Figure 3.
The degree of variability between trials in the results of exercise
capacity at the end of the intervention and serious adverse events
and ICD shock at longest available follow-up were 50% to 90%,
which might represent substantial heterogeneity. Therefore, we
assessed the risk of inconsistency as high and downgraded these
Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
23
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
results by one level. This decreases the validity of our reported
results on these outcomes. In the rest of the results, we assessed
the risk of inconsistency as not serious, which increases the validity
of our reported results.
We assessed the degree of imprecision in the results and
downgraded by one level if the number of events to calculate a
precise eEect estimate was too low or if the 95% CIs included
both no eEect and appreciable harm and appreciable benefit. This
was evident in the results of all-cause mortality, serious adverse
events, and antitachycardia pacing and shock, and therefore we
downgraded results to serious or very serious.
Potential biases in the review process
Strengths
This has been the first systematic review of RCTs assessing
the impact of exercise-based cardiac rehabilitation for adult
patients with an ICD. The review was conducted according to
the recommendations of the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011a). We followed the peer-
reviewed published protocol, which predefined participants,
interventions, comparisons, and outcomes, with the attention
of avoiding biases during review preparation. We performed
a comprehensive literature search to identify published and
unpublished studies according to our prespecified inclusion and
exclusion criteria. We located full text publications of all included
trials and conducted the meta-analysis using available data from
these trials. We assessed outcomes at two assessment time points
(end of the intervention and longest available follow-up). We
thoroughly assessed risk of bias for each trial to assess the risks
of systematic errors ('bias') (Higgins 2011a). We used sensitivity
analyses (best-worst, worst-best) to test the robustness of our
results (Higgins 2011a).
Limitations
Our review has some limitations. Firstly, most trials were relatively
small (one trial, Piccini 2013 contributed 65% of the total data)
and reported few clinical events. Secondly, although we contacted
authors for missing data or trial information, we obtained a poor
response. Thirdly, any searches hold the risk of missing items,
e.g. limitations by number of databases, and limits due to search
terms and filters. Fourthly, a longer intervention period might
aEect outcomes, as the follow-up duration and duration of exercise
programme might be too short for clinical outcomes. FiJly, because
the trials had diEerent approaches to the control groups, we
grouped the control groups into a single control, which might be to
much of a simplification.
Agreements and disagreements with other studies or
reviews
We found that exercise-based cardiac rehabilitation increased
exercise capacity at the end of the intervention, although results
should be interpreted with caution as all trials had high risk of bias
and there was evidence of substantial statistical heterogeneity. This
finding concurs with previous reviews by Pandey and colleagues
and Isaksen and colleagues. Isaksen et al concluded that exercise-
based cardiac rehabilitation improves functional capacity in
patients with ICDs and Pandey et al concluded that exercise training
in patients with ICDs is associated with improved peak oxygen
uptake (Isaksen 2012; Pandey 2017). Based on the trials identified
in this review, we found no evidence of a diEerence in the risk
of antitachycardia pacing, appropriate shock, inappropriate shock
and all shock at the end of the intervention or at longest available
follow-up. This does not concur with the review of Pandey et al,
who concluded, in pooled analyses using a random-eEects model,
that exercise training was associated with significantly lower
likelihood of ICD shock (Pandey 2017). When it comes to safety
regarding inappropriate and appropriate shock during exercise,
rehabilitation appears to be safe, as none of the trials included
in this review reported any inappropriate or appropriate shocks
during exercise. This concurs with both Isaksen et al and Pandey et
al (Isaksen 2012; Pandey 2017).
Cochrane Reviews of the eEects of exercise-based cardiac
rehabilitation have been undertaken for other heart disease
indications including heart failure and ischaemic heart disease
(Anderson 2016; Taylor 2014). These reviews demonstrate
that exercise-based cardiac rehabilitation decreases rates of
hospitalisation and increases health-related quality of life.
However, the impact of exercise-rehabilitation on these outcomes
remains unproven for patients treated with ICD, and should be the
focus of future randomised trials and updates of this Cochrane
Review.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
The European Society of Cardiology recommend exercise-based
cardiac rehabilitation for patients treated with ICD (Piepoli 2012). In
support of this, our systematic review of randomised trials showed
evidence in favour of exercise-based rehabilitation (8 to 26 weeks
of aerobic training, 2 to 7 days per week and a duration of 10 to 60
minutes per session) on short-term exercise capacity. However, the
quality of evidence is low, and there was no evidence to support
benefit in terms of mortality, ICD shock, antitachycardia pacing,
employment or health-related quality of life.
The majority of trials included in this review were based
on cardiac rehabilitation programmes that were of exercise
training alone. However, it is widely accepted that contemporary
cardiac rehabilitation is a complex intervention and should
consist of other elements, including risk factor education
and counselling (Anderson 2014) – 'comprehensive cardiac
rehabilitation'. Moreover, due to the risk of ICD shock, rehabilitation
programmes for ICD patients should contain elements of
psychoeducation for shock management.
Based on this review, exercise-based cardiac rehabilitation seems
safe, when it comes to ICD shock. Firstly, there was no diEerence
in the risk of requiring an appropriate shock, inappropriate shock
or all shock between the exercise-based cardiac rehabilitation
group and the control group, neither at end of intervention nor at
longest available follow-up aJer the intervention period. Secondly,
all trials reported that their exercise programme was safe, with
no ICD shocks during exercise. These results provide reassurance
that exercise training in patients with an ICD does not lead to an
increased incidence of appropriate shock, inappropriate shock or
all shock. However, we still do not know if exercise-based cardiac
rehabilitation for patients with ICD is safe in general, due to a small
number of non-serious and serious adverse events reported by the
trials identified in this review. There was also no information to
what happened to ICD leads in the trials, but according to Lampert
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2017, the estimated lead survival free of definite malfunction (from
implantation date) was 95% at five years among 440 participants in
organised sports.
Implications for research
This systematic review shows that well-designed adequately
powered randomised trials are needed in order to assess the
impact of exercise-based cardiac rehabilitation on the outcomes
that matter most to patients, clinicians and policy makers. These
outcomes include all-cause mortality, serious adverse events,
health-related quality of life, appropriate shock, inappropriate
shock, return to work, and costs and cost-eEectiveness (Anderson
2016; Piepoli 2012; Taylor 2014).
New trials need to be conducted with a low risk of bias and a low risk
of random errors, further they should be reported in accordance
with CONSORT guidelines for non-pharmacological interventions
(Boutron 2008). Future clinical trials of exercise-based cardiac
rehabilitation in ICD patients should also address the following
considerations.
• Address outcomes not present in this review, i.e. ICDs zones or
detection times, ICD lead failure and ICD-related complications.• Generalisability of trial populations, i.e. inclusion of women,
people with diEerent ICD types with or without cardiac
resynchronisation therapy (CRT) function, both primary and
secondary prophylactics ICD.• Interventions to minimise the risk of ICD shock, antitachycardia
pacing and increase exercise capacity and better health-related
quality of life.• Interventions to enhance long-term mortality, costs and cost-
eEectiveness, and adherence, compliance and referral to
rehabilitation programmes.
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Characteristics of included studies [ordered by study ID]
 
Methods Parallel group RCT with cross-over
Participants N Randomised: 52 (avoided training group 22; exercise group 30). No information about patients lost
to follow-up
Profile: heart failure patients with ICD (primary indication 63.5%). CRT-D: exercise group 12; usual care
group 10)
Age: 55 +/-10 years
Male: 100%
White: NS
Inclusion criteria
• Stable CHF patients in NYHA functional class II and III• Without hospital admission or change in medications in the last 3 months• No evidence of ICD discharge
Exclusion criteria
• Decompensated CHF• Uncontrolled hypertension or diabetes mellitus• Severe respiratory disease• Significant anaemia (or haemoglobin of less than 10 g/dL)• Renal insufficiency (creatinine greater than 2 mg/dL)• Inability to exercise
Interventions Exercise
• Total duration: 8 weeks• Aerobic/resistance/mix: the intervention included a mix of stretching exercises and aerobic training• Frequency: 3 days per week (for 8 weeks)• Duration: 1 hour class (8 weeks)• Intensity:aerobic training was done at 60% of peak VO2• Modality: group training at the hospital consisted of the following: 15 minutes stretching, 40 minutes
cycling, and 5 minutes recovery
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• Setting: hospital gym• Other: ns
Control
• Control group were asked to be sedentary
Outcomes • Peak VO2• QoL (Minnesota Quality of Life)• Mortality• Readmission• VT/VF• Shock• LVEF• NYHA
Country and setting Italy, single-centre trial, with a hospital setting
Follow-up • 8 weeks (exercise capacity, LVEF, NYHA, QoL)• 18 months (mortality, shock, readmission)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomisation was performed using a table of random numbers, however
there were 30 patients in the intervention group and only 22 patients in the
control group
Allocation concealment
(selection bias)
Unclear risk No information. Waiting response from author
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information. Waiting response from author
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk There was no information about dropouts or withdrawals
Selective reporting (re-
porting bias)
High risk Design paper not published. No hierarchy of outcomes
Performance bias Unclear risk No information about co-intervention. Waiting response from author
Groups balanced at base-
line bias
Unclear risk Patients well matched at baseline, however there were 30 patients in the inter-
vention group and only 22 patients in the control group
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
Belardinelli 2006  (Continued)
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For-profit bias Unclear risk No report on their source of funding
Belardinelli 2006  (Continued)
 
 
Methods Parallel group RCT
Participants N Randomised: 196 (usual care group 97; exercise group 99). 52 patients were lost to follow-up (usual
care group 26; exercise group 26)
Profile: patients with ICD (primary indication 66%, secondary indication 34%). Heart failure: usual care
group 73 (75.3%); exercise group 76 (76.8%)
Age: 57.2; SD: 13 years
Male: 79.1%
White: NS
Inclusion criteria
• First time ICD implant• Agreed to participate in the entire programme• Randomised prior to hospital discharge
Exclusion criteria
• Less than 18 years of age• Diagnosed with a psychiatric disease or a somatic disease where the disease per se or its recovery
might have influenced the outcome• Assessed to not understand the study instructions• No permission by their treating physician to participate in the exercise programme• Patients already enrolled in clinical trials that prohibited additional participation in trials
Interventions Exercise:
• Total duration: 12 weeks• Aerobic/resistance/mix: the intervention included a mix of resistance training and aerobic training• Frequency: 2 days per week (for 12 weeks)• Duration: 1 hour class (12 weeks)• Intensity: resistance training was done at 60% to 80% of one-repetition maximum, and aerobic exer-
cise at 50% to 80% of estimated maximum heart rate• Modality: group training at the hospital consisted of the following: 10 minutes warm-up, 8 minutes
biking, 8 minutes walking/jogging/running, 8 minutes individual aerobic endurance training e.g. step,
stairway or running and resistance training of the major muscle groups. The session ended with a 10-
minute cool down and relaxation period. Home training was individually planned• Setting: home or in hospital, as chosen by the patient• Other: one year of psychoeducational follow-up focusing on modifiable factors associated with poor
outcomes. Nine consultations with a cardiac nurse face-to-face (mean 60 minutes) or by phone (mean
30 minutes), as chosen by the patient
Control:
• Control group were not denied local rehabilitation
Outcomes • Peak VO2• General health measured by SF-36• Mental health (SF-36)
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• ICD therapies• Hospitalisations• Attributable direct costs• Employment status• Death
Country and setting Denmark, single-centre trial, with a home or hospital setting
Follow-up • End of treatment (VO2, SF-36, death, serious adverse event and ICD therapies)• 45 months (death and ICD therapies)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer random-number generator with voice response
Allocation concealment
(selection bias)
Low risk Independent randomisation unit
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Blinded outcome assessment
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Number and reason for dropout was described and sensitivity analyses per-
formed for primary outcomes
Selective reporting (re-
porting bias)
Low risk Design paper published (Berg 2014). Outcome described in methods are re-
ported in results
Performance bias Unclear risk Patients in the usual care group were not denied local rehabilitation, but there
were no data on wether they received local rehabilitation
Groups balanced at base-
line bias
Low risk Patients well matched at baseline
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis as well as
sensitivity analyses.
For-profit bias Low risk Reported on their source of funding with conflicts of interest
Berg 2014  (Continued)
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Participants N Randomised: 160 (usual care group 76; exercise group 84). 18 patients were lost to follow-up (usual
care group 10; exercise group 8)
Profile: patients with ICD (primary indication 43%, secondary indication 57%). Heart failure: usual care
group 78.9%; exercise group 84.4%
Age: 55+/- 22 years
Male: 77.5%
White: 84.4%
Inclusion criteria:
• ICD implantation for either primary or secondary prevention of sudden cardiac arrest• English proficient and provided informed consent• Taking β-blocker medication• Willing to complete the exercise program and all follow-ups
Exclusion criteria:
• Clinical co morbidities that impaired cognitive or physical functioning• Short Blessed score >6 representing cognitive dysfunction• Age <21 years• Alcohol Use Disorders Identification Test score ≥4 for alcohol use indicating excessive alcohol con-
sumption• Unstable angina, myocardial infarction, ICD shock, or heart surgery within the previous 3 months• Concurrent participation in an exercise program ≥60 min/5 days per week• Cardiac rhythm other than normal sinus rhythm, pacemaker dependence, or a cardiac resynchroni-
sation therapy device• Sustained ventricular arrhythmias at baseline cardiopulmonary exercise testing
Interventions Exercise:
• Total duration: 24 week• Aerobic/resistance/mix: the intervention included 2 phases, phase one: an 8-week aerobic training
component; phase two: a 16-week aerobic maintenance component• Frequency: 5 days pr week (for 8 week); 150 minutes pr week (for 16 week)• Duration: 1 hour class (8 week); 150 minutes pr week (16 week)• Intensity: week 1 to 2, 60% to 65% of heart rate reserve; Week 3 to 4,70% to 75% of heart rate reserve;
and week 5 to 8, 80% to 85% of heart rate reserve. The target heart rate during home exercise was
tailored to fall below the ICD rate threshold for tachycardia detection by at least 20 beats pr minute;
week 9-24 home walking at 80% of heart rate reserve• Modality: walking• Setting: home• Other: weekly telephone contacts
Control:
• Control group were requested not to start a new exercise program or change their exercise patterns
for the duration of the study
Outcomes • Peak CO2• ICD therapies• Hospitalisation• Musculoskeletal symptoms• Death
Dougherty 2015  (Continued)
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Country and setting USA, single centre trial (10 outpatient settings), with a home setting intervention.
Follow-up • End of intervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer random-number generator
Allocation concealment
(selection bias)
Low risk Data manager informed the study nurse of intervention group allocation
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk The statistician was not blinded to the group assignment.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Number and reason for dropout was described. Consort diagram presented.
Regression imputations for all of the missing data were simulated for both
groups, with no statistically significant changes in outcomes discovered at any
time point.
Selective reporting (re-
porting bias)
Low risk Design paper published (Dougherty 2015). Outcome described in methods are
reported in results
Performance bias Low risk No co-interventions are delivered
Groups balanced at base-
line bias
Low risk No baseline difference between groups
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
For-profit bias Low risk Reported on their source of funding with conflicts of interest
Dougherty 2015  (Continued)
 
 
Methods Parallel group RCT (pilot trial)
Participants N Randomised: 22 (control group (waiting list) 10; exercise group 12). None lost to follow-up
Profile: Patients with ICD
Age: Exercise group 60.4 yeas SD 10.13 versus control group 62.8 years SD 4.66
Male: NS
White: NS
Inclusion criteria:
Frizelle 2004 
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• Patients that had undergone implantation of an ICD for treatment of uncontrolled ventricular arrhyth-
mia due to chronic heat disease (included patients who had undergone coronary artery bypass graJ
surgery or other cardiac surgery prior to ICD implantation)
Exclusion criteria:
• Patients who were awaiting CABG and/or heart transplantation surgery or who had recently experi-
enced acute MI• Patients with idiopathic aetiology of ventricular arrhythmia;• Patients with other complicating medical conditions that would make co-operation difficult or im-
possible• Patients unable to understand English
Interventions Exercise:
• Total duration: 12 weeks• Aerobic/resistance/mix: a simple, low impact, self-paced, largely home-based exercise programme• Frequency: 7 days per week (for 12 week)• Duration: 10 minutes• Intensity: patients set their own baseline for how many of each set of exercises they could complete
within the allocated time• Modality: ns• Setting: 6 sessions at the out-patient clinic, rest done at home.• Other: psycho-education based on cognitive-behavioural therapy (6 group sessions face to face, 1 tele-
phone follow up)
Control:
• Control group received routine care including any scheduled visits to ICD patient clinics or their own
doctor
Outcomes • Anxiety• Quality of life• Perceived health state• Exercise test
Country and setting England, single-centre trial, with 6 sessions at an outpatient clinic setting; rest done in home setting
Follow-up • End of intervention, no long term follow-up because of cross-over
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No information. Waiting response from author
Allocation concealment
(selection bias)
Unclear risk No information. Waiting response from author
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Frizelle 2004  (Continued)
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information. Waiting response from author
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Number and reason for dropout was described
Selective reporting (re-
porting bias)
Unclear risk Outcome described in methods are reported in results
Performance bias Unclear risk No information about co-intervention. Waiting response from author
Groups balanced at base-
line bias
Low risk No baseline difference between groups
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
For-profit bias Unclear risk No report on their source of funding
Frizelle 2004  (Continued)
 
 
Methods Parallel group RCT (secondary analysis of a subgroup of the HF-ACTION trial)
Participants N Randomised: 1053 (usual care group 507; exercise group 546). No information about patients lost to
follow-up
Profile: patients with heat failure and ICD (CRT-D: exercise group 41% (224); usual care group 42%
(211))
Age: median 61 years
Male: 77%
White: 69%
Inclusion criteria:
• Patients with HF (NYHA functional class II – IV)• LVEF ≤ 35%
Exclusion criteria:
• Unable to exercise• Already engaged in a routine exercise programme (> 1 session/week)• Major cardiovascular event in the prior six weeks• ICD tachycardia detection limit was set below the target heart rate for exercise training
Interventions Exercise:
• Total duration: 4 years• Aerobic/resistance/mix: the intervention included 2 phases, phase one: an 12-week aerobic training
component; phase two: a continuous aerobic maintenance component up to 4 years• Frequency: 3 days pr week (for 12 week); 5 days pr week (for up to 4 years)• Duration: 15 to 35 min/session• Intensity: 60-70% of target heart rate• Modality: walking, treadmill or cycle ergometer
Piccini 2013 
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• Setting: outpatient clinic and home• Other: ns
Control:
• Control group had no restriction in activity
Outcomes • ICD shocks• VO2
Country and setting USA, multicentre trial, with an outpatient clinic and home setting
Follow-up • 12 week (primary outcome)• 4 years
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk This is a subgroup analysis of a larger trial including HF patients
Allocation concealment
(selection bias)
Low risk Patients are randomised using an interactive voice response
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Insufficiently described
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Inclompleate information
Selective reporting (re-
porting bias)
Unclear risk Post hoc analyses of a larger RCT, the outcome described in methods are re-
ported in results
Performance bias Unclear risk No restriction in activity in control group
Groups balanced at base-
line bias
Low risk Patients well matched at baseline
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
For-profit bias Low risk Reported on their source of funding with conflicts of interest
Piccini 2013  (Continued)
 
 
Methods Parallel group RCT
Piotrowicz 2015 
Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
39
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Participants N Randomised: 111 (control group 34, exercise group 77). 4 patients were lost to follow-up (control
group 2, exercise group 2)
Profile: patients with heart failure (67.3 with ICD).
Age: exercise group 54.4 yeas SD 10.9 versus control group 62.1 years SD 12.5
Male: 88.8%
White: NS
Inclusion criteria:
• Any aetiology of leJ ventricular systolic HF (as defined in the European Society of Cardiology guide-
lines) diagnosed at least for three months• LVEF 40% on echocardiography• Classified as NYHA class II or III• Clinically stable and receiving an optimal and stable medication regimen for at least four week before
enrolment• Had no contraindications to exercise training• Were able to undergo home-based cardiac tele rehabilitation
Exclusion criteria:
• Unstable angina• A history of an acute coronary syndrome within the last month• Coronary artery bypass grafting within the last two months• Initiation of CRT-P or cardiac CRT-D within the last six months• Implantation of a pacemaker and/or ICD within the last six weeks• Symptomatic and/or exercise-induced cardiac arrhythmia or conduction disturbance• Valvular or congenital heart disease requiring surgical treatment• Hypertrophic cardiomyopathy• Severe pulmonary hypertension or other severe pulmonary disease• Uncontrolled hypertension• Anaemia (haemoglobin 10.0 g/dL)• Acute and/or decompensated noncardiac disease• Physical disability related to severe musculoskeletal or neurological problems• Acute or chronic inflammatory disease• Severe psychiatric disorder• Patient refusal to participate
Interventions Exercise:
• Total duration: 8 week• Aerobic/resistance/mix: aerobic (Nordic walking)• Frequency: 5 days pr week (for 8 week)• Duration: 25-60 minutes depending on baseline VO2 (8 week)• Intensity: ns• Modality: home-based Nordic walking• Setting: home• Other: no
Control:
• Control group were not provided with a formal exercise training prescription and did not perform
supervised rehabilitation
Piotrowicz 2015  (Continued)
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Outcomes • Peak VO2• General health measured by SF-36• Workload duration in cardiopulmonary exercise test• Six-minute walking test distance• Quality of life• Medical Outcome Survey Short Form-36 (SF-36)• Serious adverse events• Adherence to and acceptance of Nordic walking
Country and setting Poland, Single-centre trial, with a home setting
Follow-up • 8 weeks
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table
Allocation concealment
(selection bias)
Unclear risk No information on concealment
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Number and reason for dropout was described
Selective reporting (re-
porting bias)
High risk LVEF was not reported after intervention as described in the methods section.
Performance bias Low risk No co-interventions are delivered
Groups balanced at base-
line bias
High risk High risk of bias due to large age difference in the two groups.
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
For-profit bias Low risk Reported on their source of funding with conflicts of interest
Piotrowicz 2015  (Continued)
 
 
Methods Parallel group RCT
Smolis-Bak 2015 
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Participants N Randomised: 52 (control group 26; exercise group 26). No information about patients lost to fol-
low-up
Profile: advanced heart failure (NYHA III) with CRT-D
Age: 60 +/-8.5 years (exercise group); 65.1 +/-8.2 (control group)
Male: 25 (96.1%) (exercise group); 22 (84.6%) (control group)
White: NS
Inclusion criteria:
• CHF of Ischaemic origin or another etiology• NYHA class III• LVEF below 35%• Planned implantation of a CRT-D device• Controlled hypertension, diabetes and other metabolic disorders• Capacity to perform treadmill exercise test• Absence of complex arrhythmia
Exclusion criteria:
• Acute or uncontrolled disorders other than CHF• Severe mobility impairment• Severe musculoskeletal conditions which preclude physical rehabilitation (orthopaedic, neurologi-
cal)• Planned cardiac surgery or percutaneous coronary interventions• Cardiac surgery or coronary angioplasty within last 3 months• Acute coronary syndrome• Stroke or TIA within last six months• Venous thrombosis or pulmonary embolism the past; significant valve and pulmonary diseases.
Interventions Exercise:
• Total duration: 11 week• Aerobic/resistance/mix: the intervention included a mix of active exercises of small and subsequently
larger muscle groups of the lower and upper limbs, respiratory exercises and range of motion exercises
of the shoulder joint on the implantation side• Frequency: 5 days per week• Duration: ns• Intensity: the mean differences between the resting heart rate and the peak heart rate for the home-
based exercise training were 10.5 ± 2.3% during the first training session and 8.7±1.7% during the last
training session while the mean rating of perceived exertion on the 10-point Borg scale was 2.9± 1.2.• Modality: group training at the hospital consisted of the following; 15 minutes stretching, 40 minutes
cycling and 5 minutes recovery• Setting: hospital Rehabilitation Unit (3 weeks on average) and at home with tele monitoring (8 week
on average).• Other: ns
Control:
• Control group had no rehabilitation after discharge from hospital
Outcomes • Peak VO2• Anaerobic threshold• Exercise tolerance (metabolic equivalents and treadmill test duration)• Six-minute walk test
Smolis-Bak 2015  (Continued)
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• Standard echocardiography• Beck Depression Inventory• QoL (Nottingham Health Profile)
Country and setting Poland. Single centre trial, with a hospital and a home setting
Follow-up • End of intervention• 12 months
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Patients were randomly allocated, but there is no information on how this was
done. Waiting response from author
Allocation concealment
(selection bias)
Unclear risk No information on concealment
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information. Waiting response from author
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No information. Waiting response from author
Selective reporting (re-
porting bias)
Low risk Outcome described in methods are reported in results.
Performance bias Unclear risk No information about co-intervention. Waiting response from author
Groups balanced at base-
line bias
High risk High risk of bias due to large age difference in the two groups.
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
For-profit bias Low risk Reported on their source of funding with conflicts of interest
Smolis-Bak 2015  (Continued)
 
 
Methods Parallel group RCT
Participants N Randomised: 84 (control group 43; exercise group 41). 12 patients were lost to follow-up (control
group 5, exercise group 7)
Profile: SHF and NYHA III with ICD
Age: 63.7+/-9.5 years (exercise group); 61.1 +/-9.7 (control group)
Smolis-Bak 2017 
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Male: 36 (87.8%) (exercise group); 40 (93.0%) (control group)
White: NS
Inclusion criteria:
• SHF of ischaemic or non-ischaemic etiology• Implanted ICD• Low LVEF (≤ 35%)• Controlled hypertension and diabetes
Exclusion criteria:
• Resynchronisation therapy• Possible indications for CRT in the future (leJ bundle branch block, QRS > 150 ms)• Severe musculoskeletal conditions which preclude physical rehabilitation (orthopaedic, neurologi-
cal)• Planned cardiac surgery or percutaneous coronary interventions, cardiac surgery or coronary angio-
plasty within the last 3 months• Acute coronary syndromes, stroke or transient ischaemic attack within the last 6 months• Venous thrombosis or pulmonary embolism in the past• Significant valvular disease• History of malignancy
Interventions Exercise:
• Total duration: 6 months• Aerobic/resistance/mix: ICD-exercise patients underwent interval workouts with a cycloergometer
and conditioning exercises with elements of resistance exercises• Frequency: 3 days pr week• Duration: cycloergometer training lasted on average 30 minutes. Resistance training lasted from 5 to
10 minutes• Intensity: cycloergometer training with a speed of 55 to 64 revolutions per minute. Resistance training
with a load of up to 50% of muscle strength. During the working phase lasting 1 minutes, the patients
performed 10–12 repetitions in one cycle.• Setting: outpatient setting• Other: ns
Control:
• Control group received standard systolic heart failure care
Outcomes • Cardiopulmonary exercise testing• Standard echocardiographic examination• 6-minute walk test
Country and setting Poland. Single-centre trial, with an outpatient setting
Follow-up • End of intervention• 12 months
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Smolis-Bak 2017  (Continued)
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Random sequence genera-
tion (selection bias)
Unclear risk Patients were randomly allocated, but there is no information on how this was
done.
Allocation concealment
(selection bias)
Unclear risk No information on concealment
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk No blinding because of the nature of exercise-based cardiac rehabilitation
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Reasons for dropouts and withdrawals were not described. There was no infor-
mation about any methods being used to handle missing data.
Selective reporting (re-
porting bias)
Low risk Outcome described in methods are reported in results.
Performance bias Low risk Co-intervention was delivered equally to both groups
Groups balanced at base-
line bias
Low risk Patients well matched at baseline
Intention-to-treat analysis Low risk Analyses were conducted according to an intention-to-treat analysis
For-profit bias Low risk Reported on their source of funding with conflicts of interest
Smolis-Bak 2017  (Continued)
CHF: systolic heart failure; CRT: cardiac resynchronisation therapy; CRT-D: cardiac resynchronisation therapy with defibrillator; CRT-P:
cardiac resynchronisation therapy with pacing; ESC: European Society of Cardiology; HF: heart failure; ICD: implantable cardioverter
defibrillator; LVEF: leJ ventricular ejection fraction; NYHA: New York Heart Association; NS: not stated; QoL: quality of life; RCT: randomised
controlled trial; SD: standard deviation; SF-36: Short Form-36 Health Survey; SHF: systolic heart failure; TIA: transient ischaemic attack;
QRS: QRS complex; VF: ventricular fibrillation; VO2: estimated oxygen consumption; VT: ventricular tachycardia.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Dougherty 2004 A randomised controlled design was not used
Dunbar 2009 Intervention was not exercise-based
Edelman 2006 Intervention was not exercise-based
Fichet 2003 A randomised controlled design was not used
Klempfner 2015 A randomised controlled design was not used
Lewin 2007 Intervention was not exercise-based
Michitaka 2017 Intervention was not exercise-based
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Study Reason for exclusion
Rakhshan 2017 No relevant outcomes reported and authors did not respond to query about measured outcomes
Russell 2015 Intervention was not exercise-based
Toise 2014 Intervention was not exercise-based
Vanhees 2004 A randomised controlled design was not used
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods Randomised controlled trial
Participants Patients with chronic heart failure, 72 completed the study (exercise training group, n = 33, 63 +/- 9
years, 88% men, and control group, n = 39, 56 +/- 11 years, 82% men)
Interventions High-intensity interval aerobic training combined with strength exercise
Outcomes • Pulse wave velocity• MLHFQ• Depression score• 6-minute walk• Peak oxygen uptake• Peak power
Notes The number of ICD patients in the trial were below 50%, and so we contacted the author to get sep-
arated data on the ICD population. The author has not returned our request.
Chrysohoou 2015 
 
 
Methods Prospective, randomised study
Participants FiJy-three patients implanted with ICDs were randomised to exercise or to control arms and fol-
lowed up for 6 months
Interventions Exercise training
Outcomes • Ejection fraction• 6-minute walk• VO2• ICD shocks
Notes It was not possible to find anything else except the conference abstract from the main search
Weretka 2010 
Emv/Vp: ; MLHFQ: Minnesota Living with Heart Failure Questionnaire; ICD: implantable cardioverter defibrillator.
 
Characteristics of ongoing studies [ordered by study ID]
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Trial name or title Implementing exercise after an (ICD) (E-ICD)
Methods A randomised controlled trial
Participants 90 participants
Interventions Home walking exercise
Outcomes • Daily activity• General health
Starting date 1 June 2018
Contact information Cynthia M Dougherty, Professor, University of Washington
Notes Not yet recruiting
NCT03544489 
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Exercise-based cardiac rehabilitation versus control at the end of the intervention
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All-cause mortality 1 196 Risk Ratio (M-H, Random, 95% CI) 1.96 [0.18, 21.26]
2 Serious adverse events 2 356 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.77, 1.44]
3 Exercise capacity (VO2 peak) (ran-
dom-effects model)
7 1485 Mean Difference (IV, Random, 95% CI) 2.27 [1.07, 3.46]
4 Exercise capacity (VO2 peak) (fixed-
effect model)
7 1485 Mean Difference (IV, Fixed, 95% CI) 0.91 [0.60, 1.21]
5 ICD, antitachycardia pacing 2 356 Risk Ratio (M-H, Random, 95% CI) 1.26 [0.84, 1.90]
6 ICD, appropriate shock 3 428 Risk Ratio (M-H, Random, 95% CI) 0.56 [0.20, 1.58]
7 ICD, inappropriate shock 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.10, 3.51]
8 Non-serious adverse events 2 271 Risk Ratio (M-H, Random, 95% CI) 5.44 [1.01, 29.32]
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Analysis 1.1.   Comparison 1 Exercise-based cardiac rehabilitation versus
control at the end of the intervention, Outcome 1 All-cause mortality.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 2/99 1/97 100% 1.96[0.18,21.26]
   
Total (95% CI) 99 97 100% 1.96[0.18,21.26]
Total events: 2 (Cardiac rehabilitation), 1 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.55(P=0.58)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 1.2.   Comparison 1 Exercise-based cardiac rehabilitation versus
control at the end of the intervention, Outcome 2 Serious adverse events.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 41/99 37/97 83.49% 1.09[0.77,1.53]
Dougherty 2015 11/84 11/76 16.51% 0.9[0.42,1.97]
   
Total (95% CI) 183 173 100% 1.05[0.77,1.44]
Total events: 52 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0; Chi2=0.18, df=1(P=0.67); I2=0%  
Test for overall effect: Z=0.32(P=0.75)  
Favours exercise-based cardiac rehabilitation 500.02 100.1 1 Favours control
 
 
Analysis 1.3.   Comparison 1 Exercise-based cardiac rehabilitation versus control at the
end of the intervention, Outcome 3 Exercise capacity (VO2 peak) (random-e;ects model).
Study or subgroup Cardiac re-
habilitation
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Belardinelli 2006 30 18.9 (2.7) 22 16.1 (2.2) 16.54% 2.8[1.47,4.13]
Berg 2014 99 23 (8.9) 97 20.8 (8.1) 11.39% 2.22[-0.16,4.6]
Dougherty 2015 68 26.9 (7.7) 74 23.4 (6) 11.83% 3.5[1.22,5.78]
Piccini 2013 452 0.7 (2.6) 400 0.1 (2.4) 20.5% 0.58[0.25,0.91]
Piotrowicz 2015 75 18.4 (4.1) 32 17.2 (3.4) 15.68% 1.2[-0.3,2.7]
Smolis-Bak 2015 26 17.2 (3.9) 26 13.4 (4.2) 12.2% 3.8[1.6,6]
Smolis-Bak 2017 41 15.6 (6) 43 12.5 (4.5) 11.86% 3.1[0.82,5.38]
   
Total *** 791   694   100% 2.27[1.07,3.46]
Heterogeneity: Tau2=1.78; Chi2=27.91, df=6(P<0.0001); I2=78.5%  
Test for overall effect: Z=3.72(P=0)  
Favours control 52.5-5 -2.5 0 Favours exercise-based cardiac reha-
bilitation
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Analysis 1.4.   Comparison 1 Exercise-based cardiac rehabilitation versus control at the
end of the intervention, Outcome 4 Exercise capacity (VO2 peak) (fixed-e;ect model).
Study or subgroup Experimental Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Belardinelli 2006 30 18.9 (2.7) 22 16.1 (2.2) 5.2% 2.8[1.47,4.13]
Berg 2014 99 23 (8.9) 97 20.8 (8.1) 1.63% 2.22[-0.16,4.6]
Dougherty 2015 68 26.9 (7.7) 74 23.4 (6) 1.77% 3.5[1.22,5.78]
Piccini 2013 452 0.7 (2.6) 400 0.1 (2.4) 83.6% 0.58[0.25,0.91]
Piotrowicz 2015 75 18.4 (4.1) 32 17.2 (3.4) 4.11% 1.2[-0.3,2.7]
Smolis-Bak 2015 26 17.2 (3.9) 26 13.4 (4.2) 1.9% 3.8[1.6,6]
Smolis-Bak 2017 41 15.6 (6) 43 12.5 (4.5) 1.78% 3.1[0.82,5.38]
   
Total *** 791   694   100% 0.91[0.6,1.21]
Heterogeneity: Tau2=0; Chi2=27.91, df=6(P<0.0001); I2=78.5%  
Test for overall effect: Z=5.84(P<0.0001)  
Favours exercise-based cardiac rehabilitation 52.5-5 -2.5 0 Favours control
 
 
Analysis 1.5.   Comparison 1 Exercise-based cardiac rehabilitation versus
control at the end of the intervention, Outcome 5 ICD, antitachycardia pacing.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 34/99 27/97 94.03% 1.23[0.81,1.88]
Dougherty 2015 4/84 2/76 5.97% 1.81[0.34,9.6]
   
Total (95% CI) 183 173 100% 1.26[0.84,1.9]
Total events: 38 (Cardiac rehabilitation), 29 (Control)  
Heterogeneity: Tau2=0; Chi2=0.19, df=1(P=0.66); I2=0%  
Test for overall effect: Z=1.12(P=0.26)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 1.6.   Comparison 1 Exercise-based cardiac rehabilitation versus
control at the end of the intervention, Outcome 6 ICD, appropriate shock.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 18/99 18/97 58.15% 0.98[0.54,1.77]
Piotrowicz 2015 1/56 2/16 15.52% 0.14[0.01,1.48]
Dougherty 2015 2/84 5/76 26.34% 0.36[0.07,1.81]
   
Total (95% CI) 239 189 100% 0.56[0.2,1.58]
Total events: 21 (Cardiac rehabilitation), 25 (Control)  
Heterogeneity: Tau2=0.39; Chi2=3.5, df=2(P=0.17); I2=42.79%  
Test for overall effect: Z=1.1(P=0.27)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Analysis 1.7.   Comparison 1 Exercise-based cardiac rehabilitation versus
control at the end of the intervention, Outcome 7 ICD, inappropriate shock.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Dougherty 2015 2/84 3/76 100% 0.6[0.1,3.51]
   
Total (95% CI) 84 76 100% 0.6[0.1,3.51]
Total events: 2 (Cardiac rehabilitation), 3 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.56(P=0.57)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 1.8.   Comparison 1 Exercise-based cardiac rehabilitation versus
control at the end of the intervention, Outcome 8 Non-serious adverse events.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Dougherty 2015 7/84 1/76 66.11% 6.33[0.8,50.3]
Piotrowicz 2015 4/77 0/34 33.89% 4.04[0.22,72.99]
   
Total (95% CI) 161 110 100% 5.44[1.01,29.32]
Total events: 11 (Cardiac rehabilitation), 1 (Control)  
Heterogeneity: Tau2=0; Chi2=0.06, df=1(P=0.8); I2=0%  
Test for overall effect: Z=1.97(P=0.05)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Comparison 2.   Exercise-based cardiac rehabilitation versus control at the end of the intervention (best-worst case
meta-analysis)
Outcome or subgroup title No. of
studies
No. of par-
ticipants
Statistical method Effect size
1 All-cause mortality 3 467 Risk Ratio (M-H, Random, 95% CI) 0.07 [0.02, 0.22]
2 Serious adverse events 3 467 Risk Ratio (M-H, Random, 95% CI) 0.58 [0.41, 0.82]
 
 
Analysis 2.1.   Comparison 2 Exercise-based cardiac rehabilitation versus control at the
end of the intervention (best-worst case meta-analysis), Outcome 1 All-cause mortality.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 2/99 27/97 68.09% 0.07[0.02,0.3]
Piotrowicz 2015 0/77 2/34 14.92% 0.09[0,1.82]
Dougherty 2015 0/84 10/76 16.99% 0.04[0,0.72]
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
   
Total (95% CI) 260 207 100% 0.07[0.02,0.22]
Total events: 2 (Cardiac rehabilitation), 39 (Control)  
Heterogeneity: Tau2=0; Chi2=0.14, df=2(P=0.93); I2=0%  
Test for overall effect: Z=4.52(P<0.0001)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 2.2.   Comparison 2 Exercise-based cardiac rehabilitation versus control at the end
of the intervention (best-worst case meta-analysis), Outcome 2 Serious adverse events.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 41/99 63/97 75.87% 0.64[0.48,0.84]
Dougherty 2015 11/84 21/76 22.84% 0.47[0.24,0.92]
Piotrowicz 2015 0/77 2/34 1.29% 0.09[0,1.82]
   
Total (95% CI) 260 207 100% 0.58[0.41,0.82]
Total events: 52 (Cardiac rehabilitation), 86 (Control)  
Heterogeneity: Tau2=0.02; Chi2=2.32, df=2(P=0.31); I2=13.87%  
Test for overall effect: Z=3.1(P=0)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Comparison 3.   Exercise-based cardiac rehabilitation versus control at the end of the intervention (worst-best case
meta-analysis)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All-cause mortality (random-ef-
fects model)
3 467 Risk Ratio (M-H, Random, 95% CI) 13.50 [3.24, 56.25]
2 All-cause mortality (fixed-effect
model)
3 467 Risk Ratio (M-H, Fixed, 95% CI) 16.78 [4.32, 65.18]
3 All-cause mortality 3 467 Risk Ratio (M-H, Random, 95% CI) 13.50 [3.24, 56.25]
4 Serious adverse events 3 467 Risk Ratio (M-H, Random, 95% CI) 1.74 [1.34, 2.27]
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Analysis 3.1.   Comparison 3 Exercise-based cardiac rehabilitation versus control at the end of the
intervention (worst-best case meta-analysis), Outcome 1 All-cause mortality (random-e;ects model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 28/99 1/97 52.2% 27.43[3.81,197.69]
Dougherty 2015 8/84 0/76 25.32% 15.4[0.9,262.39]
Piotrowicz 2015 2/77 0/34 22.47% 2.24[0.11,45.52]
   
Total (95% CI) 260 207 100% 13.5[3.24,56.25]
Total events: 38 (Cardiac rehabilitation), 1 (Control)  
Heterogeneity: Tau2=0; Chi2=1.96, df=2(P=0.38); I2=0%  
Test for overall effect: Z=3.58(P=0)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 3.2.   Comparison 3 Exercise-based cardiac rehabilitation versus control at the end of the
intervention (worst-best case meta-analysis), Outcome 2 All-cause mortality (fixed-e;ect model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Berg 2014 28/99 1/97 45.4% 27.43[3.81,197.69]
Dougherty 2015 8/84 0/76 23.58% 15.4[0.9,262.39]
Piotrowicz 2015 2/77 0/34 31.02% 2.24[0.11,45.52]
   
Total (95% CI) 260 207 100% 16.78[4.32,65.18]
Total events: 38 (Cardiac rehabilitation), 1 (Control)  
Heterogeneity: Tau2=0; Chi2=1.96, df=2(P=0.38); I2=0%  
Test for overall effect: Z=4.07(P<0.0001)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 3.3.   Comparison 3 Exercise-based cardiac rehabilitation versus control at the
end of the intervention (worst-best case meta-analysis), Outcome 3 All-cause mortality.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 28/99 1/97 52.2% 27.43[3.81,197.69]
Dougherty 2015 8/84 0/76 25.32% 15.4[0.9,262.39]
Piotrowicz 2015 2/77 0/34 22.47% 2.24[0.11,45.52]
   
Total (95% CI) 260 207 100% 13.5[3.24,56.25]
Total events: 38 (Cardiac rehabilitation), 1 (Control)  
Heterogeneity: Tau2=0; Chi2=1.96, df=2(P=0.38); I2=0%  
Test for overall effect: Z=3.58(P=0)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Analysis 3.4.   Comparison 3 Exercise-based cardiac rehabilitation versus control at the end
of the intervention (worst-best case meta-analysis), Outcome 4 Serious adverse events.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 67/99 37/97 83.97% 1.77[1.33,2.37]
Dougherty 2015 19/84 11/76 15.27% 1.56[0.8,3.07]
Piotrowicz 2015 2/77 0/34 0.77% 2.24[0.11,45.52]
   
Total (95% CI) 260 207 100% 1.74[1.34,2.27]
Total events: 88 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0; Chi2=0.14, df=2(P=0.93); I2=0%  
Test for overall effect: Z=4.13(P<0.0001)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Comparison 4.   Exercise-based cardiac rehabilitation versus control at longest follow-up
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All-cause mortality 3 332 Risk Ratio (M-H, Random, 95% CI) 1.18 [0.65, 2.14]
2 Serious adverse events (ran-
dom-effects model)
3 188 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.43, 1.65]
3 Serious adverse events (fixed-ef-
fect model)
3 188 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.61, 1.08]
4 Exercise capacity (VO2 peak) 2 136 Mean Difference (IV, Fixed, 95% CI) 0.83 [-0.66, 2.32]
5 ICD, appropriate shock (ran-
dom-effects model)
4 384 Risk Ratio (M-H, Random, 95% CI) 0.28 [0.05, 1.65]
6 ICD, appropriate shock (fixed-ef-
fect model)
4 384 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.68, 1.13]
7 ICD, all shocks 1   Risk Ratio (M-H, Random, 95% CI) Subtotals only
 
 
Analysis 4.1.   Comparison 4 Exercise-based cardiac rehabilitation
versus control at longest follow-up, Outcome 1 All-cause mortality.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Berg 2014 19/99 12/97 65.73% 1.55[0.8,3.02]
Smolis-Bak 2015 3/26 3/26 14.98% 1[0.22,4.5]
Smolis-Bak 2017 3/41 6/43 19.29% 0.52[0.14,1.96]
   
Total (95% CI) 166 166 100% 1.18[0.65,2.14]
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Total events: 25 (Cardiac rehabilitation), 21 (Control)  
Heterogeneity: Tau2=0.02; Chi2=2.15, df=2(P=0.34); I2=6.8%  
Test for overall effect: Z=0.54(P=0.59)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 4.2.   Comparison 4 Exercise-based cardiac rehabilitation versus control
at longest follow-up, Outcome 2 Serious adverse events (random-e;ects model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 2006 0/30 8/22 5.24% 0.04[0,0.72]
Smolis-Bak 2015 14/26 15/26 44.64% 0.93[0.57,1.52]
Smolis-Bak 2017 25/41 25/43 50.12% 1.05[0.74,1.49]
   
Total (95% CI) 97 91 100% 0.84[0.43,1.65]
Total events: 39 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0.2; Chi2=6.48, df=2(P=0.04); I2=69.15%  
Test for overall effect: Z=0.5(P=0.62)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 4.3.   Comparison 4 Exercise-based cardiac rehabilitation versus control
at longest follow-up, Outcome 3 Serious adverse events (fixed-e;ect model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Belardinelli 2006 0/30 8/22 19.85% 0.04[0,0.72]
Smolis-Bak 2015 14/26 15/26 30.51% 0.93[0.57,1.52]
Smolis-Bak 2017 25/41 25/43 49.64% 1.05[0.74,1.49]
   
Total (95% CI) 97 91 100% 0.81[0.61,1.08]
Total events: 39 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0; Chi2=6.48, df=2(P=0.04); I2=69.15%  
Test for overall effect: Z=1.42(P=0.16)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 4.4.   Comparison 4 Exercise-based cardiac rehabilitation versus
control at longest follow-up, Outcome 4 Exercise capacity (VO2 peak).
Study or subgroup Cardiac re-
habilitation
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Smolis-Bak 2015 26 13.1 (4.1) 26 14.3 (3.1) 56.83% -1.2[-3.18,0.78]
Favours exercise-based cardiac rehabilitation 10050-100 -50 0 Favours control
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Study or subgroup Cardiac re-
habilitation
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Smolis-Bak 2017 41 15.9 (6.1) 43 12.4 (4.3) 43.17% 3.5[1.23,5.77]
   
Total *** 67   69   100% 0.83[-0.66,2.32]
Heterogeneity: Tau2=0; Chi2=9.39, df=1(P=0); I2=89.34%  
Test for overall effect: Z=1.09(P=0.28)  
Favours exercise-based cardiac rehabilitation 10050-100 -50 0 Favours control
 
 
Analysis 4.5.   Comparison 4 Exercise-based cardiac rehabilitation versus control
at longest follow-up, Outcome 5 ICD, appropriate shock (random-e;ects model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 2006 0/30 8/22 18.58% 0.04[0,0.72]
Berg 2014 59/99 49/97 34.59% 1.18[0.91,1.52]
Smolis-Bak 2015 1/26 5/26 23.52% 0.2[0.03,1.6]
Smolis-Bak 2017 1/41 5/43 23.32% 0.21[0.03,1.72]
   
Total (95% CI) 196 188 100% 0.28[0.05,1.65]
Total events: 61 (Cardiac rehabilitation), 67 (Control)  
Heterogeneity: Tau2=2.33; Chi2=13.23, df=3(P=0); I2=77.32%  
Test for overall effect: Z=1.41(P=0.16)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 4.6.   Comparison 4 Exercise-based cardiac rehabilitation versus control
at longest follow-up, Outcome 6 ICD, appropriate shock (fixed-e;ect model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Belardinelli 2006 0/30 8/22 14.12% 0.04[0,0.72]
Berg 2014 59/99 49/97 71.59% 1.18[0.91,1.52]
Smolis-Bak 2015 1/26 5/26 7.23% 0.2[0.03,1.6]
Smolis-Bak 2017 1/41 5/43 7.06% 0.21[0.03,1.72]
   
Total (95% CI) 196 188 100% 0.88[0.68,1.13]
Total events: 61 (Cardiac rehabilitation), 67 (Control)  
Heterogeneity: Tau2=0; Chi2=13.23, df=3(P=0); I2=77.32%  
Test for overall effect: Z=1(P=0.32)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Analysis 4.7.   Comparison 4 Exercise-based cardiac rehabilitation
versus control at longest follow-up, Outcome 7 ICD, all shocks.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Piccini 2013 108/546 113/507 0% 0.89[0.7,1.12]
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Comparison 5.   Exercise-based cardiac rehabilitation versus control at longest follow-up (best-worst case meta-
analysis)
Outcome or subgroup title No. of
studies
No. of par-
ticipants
Statistical method Effect size
1 All-cause mortality 4 384 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.32, 0.74]
2 Serious adverse events 3 188 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.55, 0.93]
 
 
Analysis 5.1.   Comparison 5 Exercise-based cardiac rehabilitation versus control at
longest follow-up (best-worst case meta-analysis), Outcome 1 All-cause mortality.
Study or subgroup Cardiac reha-
bilitational
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 2006 0/30 0/22   Not estimable
Berg 2014 19/99 38/97 79.7% 0.49[0.3,0.79]
Smolis-Bak 2015 3/26 3/26 7.91% 1[0.22,4.5]
Smolis-Bak 2017 3/41 11/43 12.39% 0.29[0.09,0.95]
   
Total (95% CI) 196 188 100% 0.48[0.32,0.74]
Total events: 25 (Cardiac rehabilitational), 52 (Control)  
Heterogeneity: Tau2=0; Chi2=1.64, df=2(P=0.44); I2=0%  
Test for overall effect: Z=3.35(P=0)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 5.2.   Comparison 5 Exercise-based cardiac rehabilitation versus control at
longest follow-up (best-worst case meta-analysis), Outcome 2 Serious adverse events.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Belardinelli 2006 0/30 8/22 17.43% 0.04[0,0.72]
Smolis-Bak 2015 14/26 15/26 26.79% 0.93[0.57,1.52]
Smolis-Bak 2017 25/41 32/43 55.78% 0.82[0.61,1.11]
   
Total (95% CI) 97 91 100% 0.71[0.55,0.93]
Total events: 39 (Cardiac rehabilitation), 55 (Control)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Tau2=0; Chi2=5.78, df=2(P=0.06); I2=65.42%  
Test for overall effect: Z=2.51(P=0.01)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Comparison 6.   Exercise-based cardiac rehabilitation versus control at longest follow-up (worst-best case meta-
analysis)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All-cause mortality 4 384 Risk Ratio (M-H, Random, 95% CI) 2.29 [1.12, 4.70]
2 Serious adverse events (random-ef-
fects model)
3 188 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.42, 1.89]
3 Serious adverse events (fixed-effect
model)
3 188 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.55, 0.93]
 
 
Analysis 6.1.   Comparison 6 Exercise-based cardiac rehabilitation versus control at
longest follow-up (worst-best case meta-analysis), Outcome 1 All-cause mortality.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 2006 0/30 0/22   Not estimable
Berg 2014 45/99 12/97 49.62% 3.67[2.07,6.51]
Smolis-Bak 2015 3/26 3/26 17.25% 1[0.22,4.5]
Smolis-Bak 2017 10/41 6/43 33.13% 1.75[0.7,4.37]
   
Total (95% CI) 196 188 100% 2.29[1.12,4.7]
Total events: 58 (Cardiac rehabilitation), 21 (Control)  
Heterogeneity: Tau2=0.18; Chi2=3.66, df=2(P=0.16); I2=45.35%  
Test for overall effect: Z=2.27(P=0.02)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 6.2.   Comparison 6 Exercise-based cardiac rehabilitation versus control at longest follow-
up (worst-best case meta-analysis), Outcome 2 Serious adverse events (random-e;ects model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 2006 0/30 8/22 6.33% 0.04[0,0.72]
Smolis-Bak 2015 14/26 15/26 44.18% 0.93[0.57,1.52]
Smolis-Bak 2017 30/41 25/43 49.49% 1.26[0.92,1.72]
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
   
Total (95% CI) 97 91 100% 0.89[0.42,1.89]
Total events: 44 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0.27; Chi2=8.42, df=2(P=0.01); I2=76.25%  
Test for overall effect: Z=0.3(P=0.76)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 6.3.   Comparison 6 Exercise-based cardiac rehabilitation versus control at longest follow-
up (worst-best case meta-analysis), Outcome 3 Serious adverse events (fixed-e;ect model).
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Belardinelli 2006 0/30 8/22 17.43% 0.04[0,0.72]
Smolis-Bak 2015 14/26 15/26 26.79% 0.93[0.57,1.52]
Smolis-Bak 2017 25/41 32/43 55.78% 0.82[0.61,1.11]
   
Total (95% CI) 97 91 100% 0.71[0.55,0.93]
Total events: 39 (Cardiac rehabilitation), 55 (Control)  
Heterogeneity: Tau2=0; Chi2=5.78, df=2(P=0.06); I2=65.42%  
Test for overall effect: Z=2.51(P=0.01)  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Comparison 7.   Subgroup analysis
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All-cause mortality: exercise intervention on-
ly compared to exercise intervention plus any
other co-intervention at longest follow-up
2 248 Risk Ratio (M-H, Random, 95% CI) 1.44 [0.79, 2.65]
1.1 Exercise intervention only 1 52 Risk Ratio (M-H, Random, 95% CI) 1.0 [0.22, 4.50]
1.2 Exercise intervention plus any other co-in-
tervention
1 196 Risk Ratio (M-H, Random, 95% CI) 1.55 [0.80, 3.02]
2 Serious adverse events: follow-up 5 544 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.74, 1.30]
2.1 Follow-up less than six months 2 356 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.77, 1.44]
2.2 Follow-up six months or more 3 188 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.43, 1.65]
3 Serious adverse events: exercise intervention
only compared to exercise intervention plus
any other co-intervention at end of interven-
tion
2 356 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.77, 1.44]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
3.1 Exercise intervention only 1 160 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.42, 1.97]
3.2 Exercise intervention plus any other co-in-
tervention
1 196 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.77, 1.53]
 
 
Analysis 7.1.   Comparison 7 Subgroup analysis, Outcome 1 All-cause mortality: exercise intervention
only compared to exercise intervention plus any other co-intervention at longest follow-up.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
7.1.1 Exercise intervention only  
Smolis-Bak 2015 3/26 3/26 16.38% 1[0.22,4.5]
Subtotal (95% CI) 26 26 16.38% 1[0.22,4.5]
Total events: 3 (Cardiac rehabilitation), 3 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
7.1.2 Exercise intervention plus any other co-intervention  
Berg 2014 19/99 12/97 83.62% 1.55[0.8,3.02]
Subtotal (95% CI) 99 97 83.62% 1.55[0.8,3.02]
Total events: 19 (Cardiac rehabilitation), 12 (Control)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.29(P=0.2)  
   
Total (95% CI) 125 123 100% 1.44[0.79,2.65]
Total events: 22 (Cardiac rehabilitation), 15 (Control)  
Heterogeneity: Tau2=0; Chi2=0.27, df=1(P=0.6); I2=0%  
Test for overall effect: Z=1.18(P=0.24)  
Test for subgroup differences: Chi2=0.27, df=1 (P=0.6), I2=0%  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 7.2.   Comparison 7 Subgroup analysis, Outcome 2 Serious adverse events: follow-up.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
7.2.1 Follow-up less than six months  
Berg 2014 41/99 37/97 33.23% 1.09[0.77,1.53]
Dougherty 2015 11/84 11/76 10.94% 0.9[0.42,1.97]
Subtotal (95% CI) 183 173 44.17% 1.05[0.77,1.44]
Total events: 52 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0; Chi2=0.18, df=1(P=0.67); I2=0%  
Test for overall effect: Z=0.32(P=0.75)  
   
7.2.2 Follow-up six months or more  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
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Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 2006 0/30 8/22 0.99% 0.04[0,0.72]
Smolis-Bak 2015 14/26 15/26 22.32% 0.93[0.57,1.52]
Smolis-Bak 2017 25/41 25/43 32.52% 1.05[0.74,1.49]
Subtotal (95% CI) 97 91 55.83% 0.84[0.43,1.65]
Total events: 39 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0.2; Chi2=6.48, df=2(P=0.04); I2=69.15%  
Test for overall effect: Z=0.5(P=0.62)  
   
Total (95% CI) 280 264 100% 0.99[0.74,1.3]
Total events: 91 (Cardiac rehabilitation), 96 (Control)  
Heterogeneity: Tau2=0.03; Chi2=5.83, df=4(P=0.21); I2=31.45%  
Test for overall effect: Z=0.1(P=0.92)  
Test for subgroup differences: Chi2=0.35, df=1 (P=0.56), I2=0%  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
Analysis 7.3.   Comparison 7 Subgroup analysis, Outcome 3 Serious adverse events: exercise intervention
only compared to exercise intervention plus any other co-intervention at end of intervention.
Study or subgroup Cardiac re-
habilitation
Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
7.3.1 Exercise intervention only  
Dougherty 2015 11/84 11/76 16.51% 0.9[0.42,1.97]
Subtotal (95% CI) 84 76 16.51% 0.9[0.42,1.97]
Total events: 11 (Cardiac rehabilitation), 11 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.25(P=0.8)  
   
7.3.2 Exercise intervention plus any other co-intervention  
Berg 2014 41/99 37/97 83.49% 1.09[0.77,1.53]
Subtotal (95% CI) 99 97 83.49% 1.09[0.77,1.53]
Total events: 41 (Cardiac rehabilitation), 37 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.47(P=0.64)  
   
Total (95% CI) 183 173 100% 1.05[0.77,1.44]
Total events: 52 (Cardiac rehabilitation), 48 (Control)  
Heterogeneity: Tau2=0; Chi2=0.18, df=1(P=0.67); I2=0%  
Test for overall effect: Z=0.32(P=0.75)  
Test for subgroup differences: Chi2=0.18, df=1 (P=0.67), I2=0%  
Favours exercise-based cardiac rehabilitation 1000.01 100.1 1 Favours control
 
 
A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL
#1 MeSH descriptor: [Exercise] explode all trees
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#2 exercis*
#3 MeSH descriptor: [Exercise Therapy] explode all trees
#4 MeSH descriptor: [Exercise Tolerance] this term only
#5 MeSH descriptor: [Sports] explode all trees
#6 sport*
#7 MeSH descriptor: [Physical Exertion] this term only
#8 exertion
#9 MeSH descriptor: [Physical Fitness] this term only
#10 (fitness or fitter or fit)
#11 MeSH descriptor: [Physical Education and Training] explode all trees
#12 (muscle* near/3 (train* or activ*))
#13 (train* near/5 (strength* or aerobic* or exercise*))
#14 ((aerobic or resistance) near/3 (train* or activ*))
#15 (physical* near/5 (fit* or train* or therap* or activ* or strength or endur* or exert* or capacit*))
#16 ((exercise* or fitness) near/3 (treat* or interven* or program* or train* or physical or activ*))
#17 MeSH descriptor: [Rehabilitation] this term only
#18 MeSH descriptor: [Rehabilitation Centers] this term only
#19 rehabilitat*
#20 MeSH descriptor: [Dance Therapy] this term only
#21 kinesiotherap*
#22 danc*
#23 (("lifestyle" or life-style or "life style") near/5 activ*)
#24 (("lifestyle" or life-style or "life style") near/5 physical*)
#25 ((lifestyle or life-style or "life style") near/5 (intervent* or program* or treatment*))
#26 walk*
#27 run*
#28 jog*
#29 MeSH descriptor: [Patient Education as Topic] this term only
#30 (patient* near/5 educat*)
#31 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or
#22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30
#32 MeSH descriptor: [Defibrillators, Implantable] this term only
#33 (implantable near/2 defibrill*)
#34 (cardioverter near/2 defibrill*)
#35 ICD
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#36 ICD-CRT
#37 #32 or #33 or #34 or #35 or #36
#38 #31 and #37
MEDLINE Ovid
1. exp Exercise/
2. exercis*.tw.
3. exp Exercise Therapy/
4. Exercise Tolerance/
5. exp Sports/
6. sport*.tw.
7. Physical Exertion/
8. exertion.tw.
9. Physical Fitness/
10. (fitness or fitter or fit).tw.
11. exp "Physical Education and Training"/
12. (muscle* adj3 (train* or activ*)).tw.
13. (train* adj5 (strength* or aerobic* or exercise*)).tw.
14. ((aerobic or resistance) adj3 (train* or activ*)).tw.
15. (physical* adj5 (fit* or train* or therap* or activ* or strength or endur* or exert* or capacit*)).tw.
16. ((exercise* or fitness) adj3 (treat* or interven* or program* or train* or physical or activ*)).tw.
17. Rehabilitation/
18. Rehabilitation Centers/
19. rehabilitat*.tw.
20. Dance Therapy/
21. kinesiotherap*.tw.
22. danc*.tw.
23. (("lifestyle" or life-style) adj5 activ*).tw.
24. (("lifestyle" or life-style) adj5 physical*).tw.
25. ((lifestyle or life-style) adj5 (intervent* or program* or treatment*)).tw.
26. walk*.tw.
27. run*.tw.
28. jog*.tw.
29. Patient Education as Topic/
30. (patient* adj5 educat*).tw.
31. or/1-30
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32. Defibrillators, Implantable/
33. (implantable adj2 defibrill*).tw.
34. (cardioverter adj2 defibrill*).tw.
35. ICD.tw.
36. ICD-CRT.tw.
37. or/32-36
38. randomized controlled trial.pt.
39. controlled clinical trial.pt.
40. randomized.ab.
41. placebo.ab.
42. drug therapy.fs.
43. randomly.ab.
44. trial.ab.
45. groups.ab.
46. 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45
47. exp animals/ not humans.sh.
48. 46 not 47
49. 31 and 37 and 48
Embase Ovid
1. exp exercise/
2. exercis*.tw.
3. exp kinesiotherapy/
4. exercise tolerance/
5. exp sport/
6. sport*.tw.
7. exertion.tw.
8. fitness/
9. (fitness or fitter or fit).tw.
10. physical education/
11. (muscle* adj3 (train* or activ*)).tw.
12. (train* adj5 (strength* or aerobic* or exercise*)).tw.
13. ((aerobic or resistance) adj3 (train* or activ*)).tw.
14. (physical* adj5 (fit* or train* or therap* or activ* or strength or endur* or exert* or capacit*)).tw.
15. ((exercise* or fitness) adj3 (treat* or interven* or program* or train* or physical or activ*)).tw.
16. rehabilitation/
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17. rehabilitation center/
18. rehabilitat*.tw.
19. dance therapy/
20. kinesiotherap*.tw.
21. danc*.tw.
22. (("lifestyle" or life-style) adj5 activ*).tw.
23. (("lifestyle" or life-style) adj5 physical*).tw.
24. ((lifestyle or life-style) adj5 (intervent* or program* or treatment*)).tw.
25. walk*.tw.
26. run*.tw.
27. jog*.tw.
28. patient education/
29. (patient* adj5 educat*).tw.
30. or/1-29
31. implantable cardioverter defibrillator/
32. (implantable adj2 defibrill*).tw.
33. (cardioverter adj2 defibrill*).tw.
34. ICD.tw.
35. ICD-CRT.tw.
36. or/31-35
37. 30 and 36
38. random$.tw.
39. factorial$.tw.
40. crossover$.tw.
41. cross over$.tw.
42. cross-over$.tw.
43. placebo$.tw.
44. (doubl$ adj blind$).tw.
45. (singl$ adj blind$).tw.
46. assign$.tw.
47. allocat$.tw.
48. volunteer$.tw.
49. crossover procedure/
50. double blind procedure/
51. randomized controlled trial/
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52. single blind procedure/
53. 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52
54. (animal/ or nonhuman/) not human/
55. 53 not 54
56. 37 and 55
57. limit 56 to embase
PsycINFO
1. exp exercise/
2. exercis*.tw.
3. exp sports/
4. sport*.tw.
5. exertion.tw.
6. physical fitness/
7. (fitness or fitter or fit).tw.
8. physical education/
9. (muscle* adj3 (train* or activ*)).tw.
10. (train* adj5 (strength* or aerobic* or exercise*)).tw.
11. ((aerobic or resistance) adj3 (train* or activ*)).tw.
12. (physical* adj5 (fit* or train* or therap* or activ* or strength or endur* or exert* or capacit*)).tw.
13. ((exercise* or fitness) adj3 (treat* or interven* or program* or train* or physical or activ*)).tw.
14. rehabilitation/
15. rehabilitat*.tw.
16. kinesiotherap*.tw.
17. danc*.tw.
18. (("lifestyle" or life-style) adj5 activ*).tw.
19. (("lifestyle" or life-style) adj5 physical*).tw.
20. ((lifestyle or life-style) adj5 (intervent* or program* or treatment*)).tw.
21. walk*.tw.
22. run*.tw.
23. jog*.tw.
24. (patient* adj5 educat*).tw.
25. or/1-24
26. (implantable adj2 defibrill*).tw.
27. (cardioverter adj2 defibrill*).tw.
28. ICD.tw.
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29. ICD-CRT.tw.
30. or/26-29
31. 25 and 30
32. random$.tw.
33. factorial$.tw.
34. crossover$.tw.
35. cross-over$.tw.
36. placebo$.tw.
37. (doubl$ adj blind$).tw.
38. (singl$ adj blind$).tw.
39. assign$.tw.
40. allocat$.tw.
41. volunteer$.tw.
42. control*.tw.
43. "2000".md.
44. or/32-43
45. 31 and 44
CINAHL
S46S27 AND S45
S45S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41 or S42 or S43 or S44
S44TX cross-over*
S43TX crossover*
S42TX volunteer*
S41(MH "Crossover Design")
S40TX allocat*
S39TX control*
S38TX assign*
S37TX placebo*
S36(MH "Placebos")
S35TX random*
S34TX (doubl* N1 mask*)
S33TX (singl* N1 mask*)
S32TX (doubl* N1 blind*)
S31TX (singl* N1 blind*)
S30TX (clinic* N1 trial?)
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S29PT clinical trial
S28(MH "Clinical Trials+")
S27S21 AND S26
S26S22 OR S23 OR S24 OR S25
S25ICD
S24"cardioverter defibrill*"
S23"implantable defibrill*"
S22(MH "Defibrillators, Implantable")
S21S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20
S20"patient* educat*"
S19walk* or run* or jog*
S18"life style" or life-style of lifestyle
S17danc*
S16kinesiotherap*
S15rehabilitat*
S14(MH "Rehabilitation")
S13"aerobic train*" or "resistance train"
S12"train* strength*" or "train* aerobic*" or "train* exercise*"
S11"muscle* train*" or "muscle* activ*"
S10(fitness or fitter or fit)
S9(MH "Physical Fitness")
S8exertion
S7(MH "Exertion+")
S6sport*
S5(MH "Sports+")
S4(MH "Exercise Tolerance+")
S3(MH "Therapeutic Exercise+")
S2exercis*
S1(MH "Exercise+")
LILACS
(exercis$ OR sport$ OR physical$ OR train$ OR activ$) [Words] and defibrill$ [Words]
Web of Science
# 8 #7 AND #6
# 7 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*)
# 6 #5 AND #4
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# 5 TS=(defibrill* or cardioverter or ICD)
# 4 #3 OR #2 OR #1
# 3 TS=("patient educat*")
# 2 TS=(rehabilitat* or danc* or kinesiotherap* or walk* or run* or jog* of lifestyle or life-style or "life style")
# 1 TS=(exercis* or sport* or exertion or fitness or fitter or fit or train* or activ*)
Clinical trial registers
1 implantable cardiac defibrillator
2 ICD
3 rehabilitation
4 exercise
Appendix 2. Detailed criteria for all risk of bias domains
Generation of random sequence• Low risk of bias: sequence generated using a computer random-number generator or a table of random numbers. Drawing lots, tossing
a coin, shuEling cards or envelopes, and throwing dice are all adequate if performed by an independent adjudicator, or the method is
unlikely to introduce selection bias;• Unclear risk of bias: insuEicient information provided to assess whether the method used could cause bias;• High risk of bias: the method used is improper and likely to be confounding (e.g. there is a non-random component in the generation
of the sequence).
Allocation concealment• Low risk of bias: the method used will probably not cause bias on the final observed eEect (e.g. allocation is controlled by a central
and independent randomisation unit and the assignment cannot be foreseen);• Unclear risk of bias: insuEicient information about concealment of allocation provided to assess whether the method used could cause
bias on the estimate of the eEect;• High risk of bias: the method used will probably cause bias on the final observed eEect (e.g. the allocation sequence is open and known
to the trial investigators).
Blinding of participants and personnel• Low risk of bias: any intervention is delivered blinded to the participants or personnel, or both, and neither the participants nor the
personnel are aware of the group to which participants are allocated;• Unclear risk of bias: there is insuEicient information to assess whether the participants or personnel are blinded to the intervention;• High risk of bias: the patients and personnel are not blinded to the intervention.
Due to the type of intervention being investigated in this Cochrane Review, we expect high risk of bias in this domain. This applied to all
included studies, as it is impossible to blind participants when the intervention consists of physical exercise.
Blinding of outcome assessment• Low risk of bias: if the trial investigators performing the outcome assessments are blinded to the treatment allocation, and this is
described;• Unclear risk of bias: if the procedure of blinding is insuEiciently described;• High risk of bias: if blinding is not performed, or the procedure cannot be classified as at 'low risk of bias'.
Incomplete outcome data• Low risk of bias: the number and reasons for dropouts and withdrawals are properly described, and valid methods, such as multiple
imputation, have been used to handle missing data;• Unclear risk of bias: the study made the impression of having no dropouts or withdrawals, but this aspect was described insuEiciently;• High risk of bias: if the pattern of dropouts can be described as being diEerent in the two intervention groups or the methods being
used to handle missing data were unsatisfactory (e.g. last observation carried forward).
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Selective outcome reporting• Low risk of bias: all primary and clinically relevant outcomes of the trial were reported. The hierarchy of the outcome measures are
documented in a protocol before launch of randomisation;• Unclear risk of bias: not all primary or clinically relevant outcomes are reported, or reported suEiciently, or whether these outcomes
were recorded is unclear;• High risk of bias: not all primary or clinically relevant outcomes reported.
Performance bias• Low risk of bias: any co-interventions are delivered equally across intervention and control groups;• Unclear risk of bias: there is insuEicient information to assess whether co-interventions were present, or equally delivered across
groups, and that could put the trial at a risk of bias;• High risk of bias: the co-interventions are not delivered equally across intervention and control groups.
Intention-to-treat (ITT) analysis• Low risk of bias: the trial reports the analysis were conducted according to an ITT analysis, which include all the principles of such
analysis, e.g. keeping participants in the intervention groups to which they were randomised, regardless of the intervention they
actually received; and measure outcome data on all or the majority of participants (i.e. > 90% of those randomised) or include imputation
of all missing data in the analysis, using appropriate methodology, e.g. multiple imputation;• Unclear risk of bias: it is unclear if and how the trial has performed an ITT analysis;• High risk of bias: the trial does not include an ITT analysis, or there is a substantive loss of outcome data (e.g. > 20%) and analyses are
performed according to imputation methods known to create bias, such as last observation carried forward.
Groups balanced at baseline• Low risk of bias: if the characteristics of the participants before the start of intervention in the intervention/control groups are reported
to be comparable or can be judged to be comparable in terms of likely main prognostic factors;• Unclear risk of bias: it is not reported whether the participants' characteristics between groups are balanced at baseline and there is
inadequate information reported to assess this;• High risk of bias: if there is evidence of substantive imbalance in the baseline characteristics of the intervention/control groups with
regard to likely major prognostic factors.
For-profit bias• Low risk of bias: the trial was free of industry sponsorship or other support from a for-profit organisation that may have an interest
in a given result;• Unclear risk of bias: it was unclear how the trial was funded;• High risk of bias: the trial was sponsored by the industry or had received other support from a for-profit organisation that may have
had an interest in a given result.
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